|
|
|
|
| Transient Receptor Potential Cation Channel Subfamily V and Breast Cancer
So, C.;
Milevskiy, M.;
Monteith, G. |
Lab Invest |
2019-12-10 |
11.48 | Dec 12 |
| Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
Samaan, T.;
Samec, M.;
Liskova, A.;
Kubatka, P.;
Büsselberg, D. |
Biomolecules |
2019-11-27 |
11.47 | Dec 5 |
| Distinct Functions of AKT Isoforms in Breast Cancer: A Comprehensive Review
Hinz, N.;
Jücker, M. |
Cell Commun Signal |
2019-11-21 |
11.46 | Nov 28 |
| KISS1 in Breast Cancer Progression and Autophagy
Ulasov, I.;
Borovjagin, A.;
Timashev, P.;
Cristofanili, M.;
Welch, D. |
Cancer Metastasis Rev |
2019-11-16 |
11.45 | Nov 21 |
| The Aryl Hydrocarbon Receptor (AhR) as a Breast Cancer Drug Target
Baker, J.;
Sakoff, J.;
McCluskey, A. |
Med Res Rev |
2019-11-12 |
11.44 | Nov 14 |
| Evidence for a Causal Role by Mouse Mammary Tumor-Like Virus in Human Breast Cancer
Lawson, J.;
Glenn, W. |
npj Breast Cancer |
2019-11-07 |
11.43 | Nov 7 |
| Recent Advances in Nanotheranostics for Triple Negative Breast Cancer Treatment
Thakur, V.;
Kutty, R. |
J Exp Clin Cancer Res |
2019-10-28 |
11.42 | Oct 31 |
| Single Peptides and Combination Modalities for Triple Negative Breast Cancer
Razazan, A.;
Behravan, J. |
J Cell Physiol |
2019-10-22 |
11.41 | Oct 24 |
| MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
Rahman, M.;
Brane, A.;
Tollefsbol, T. |
Cells |
2019-10-19 |
11.40 | Oct 17 |
| Metabolic Crosstalk in the Breast Cancer Microenvironment
Dias, A.;
Almeida, C.;
Helguero, L.;
Duarte, I. |
Eur J Cancer |
2019-09-29 |
11.39 | Oct 10 |
| The Regulatory Role of MicroRNAs in Breast Cancer
Loh, H.;
Norman, B.;
Lai, K.;
Rahman, N.;
Alitheen, N.;
Osman, M. |
Int J Mol Sci |
2019-10-06 |
11.39 | Oct 10 |
| Breast Cancer
Harbeck, N.;
Llorca-Penault, F.;
Cortes, J.;
Gnant, M.;
Houssami, N.;
Et al. |
Nat Rev Dis Primers |
2019-09-23 |
11.38 | Oct 3 |
| Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation
Hass, R.;
Ohe, J.;
Ungefroren, H. |
Cancers |
2019-09-25 |
11.38 | Oct 3 |
| HER2-Targeted Therapies — A Role beyond Breast Cancer
Oh, DY;
Bang, YJ |
Nat Rev Clin Oncol |
2019-09-23 |
11.37 | Sep 26 |
| Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
Wang, J.;
Xu, B. |
Signal Transduct Target Ther |
2019-09-13 |
11.36 | Sep 19 |
| Cancer-Associated Adipocytes: Key Players in Breast Cancer Progression
Wu, Q.;
Li, Z.;
Li, J.;
Sun, S.;
Sun, S. |
J Hematol Oncol |
2019-09-10 |
11.35 | Sep 12 |
| Panoptic View of Prognostic Models for Personalized Breast Cancer Management
Saini, G.;
Mittal, K.;
Rida, P.;
Janssen, E.;
Gogineni, K.;
Aneja, R. |
Cancers |
2019-09-07 |
11.35 | Sep 12 |
| Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
Nedeljkovic, M;
Damjanovic, A |
Cells |
2019-08-22 |
11.34 | Sep 5 |
| Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response
Bhat, V.;
Allan, A.;
Raouf, A. |
Cancers |
2019-08-24 |
11.33 | Aug 29 |
| Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
Miglietta, F.;
Griguolo, G.;
Guarneri, V.;
Dieci, M. |
Oncologist |
2019-08-23 |
11.33 | Aug 29 |
| Inflammatory Breast Cancer: a Separate Entity
Rosenbluth, J.;
Overmoyer, B. |
Curr Oncol Rep |
2019-08-15 |
11.32 | Aug 22 |
| PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
van Attikum, H.;
Noordermeer, S. |
Trends Cell Biol |
2019-08-14 |
11.31 | Aug 15 |
| Epithelial-to-Mesenchymal Transition and Invadopodia Markers in Breast Cancer: Lumican a Key Regulator
Karamanou, K.;
Franchi, M.;
Vynios, D.;
Brézillon, S. |
Semin Cancer Biol |
2019-08-08 |
11.31 | Aug 15 |
| SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis
Batham, J.;
Lim, P.;
Rao, S. |
Cancers |
2019-08-09 |
11.31 | Aug 15 |
| Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention
Slepicka, P.;
Cyrill, S.;
dos Santos, C. |
Trends Mol Med |
2019-08-02 |
11.30 | Aug 8 |
| 3D Printing Breast Tissue Models: A Review of Past Work and Directions for Future Work
Cleversey, C.;
Robinson, M.;
Willerth, S. |
Micromachines |
2019-07-27 |
11.30 | Aug 8 |
| Defining and Modulating ‘BRCAness’
Byrum. A.;
Vindigni, A.;
Mosammaparast, N. |
Trends Cell Biol |
2019-07-27 |
11.29 | Aug 1 |
| 3D Printing Breast Tissue Models: A Review of Past Work and Directions for Future Work
Cleversey, C.;
Robinson, M.;
Willerth, S. |
Micromachines |
1019-07-27 |
11.29 | Aug 1 |
| Notch Signaling in Breast Cancer: From Pathway Analysis to Therapy
Krishna, B.;
Jana, S.;
Singhal, J.;
Horne, D.;
Awasthi, S.;
Et al. |
Cancer Lett |
2019-07-18 |
11.28 | Jul 25 |
| Estrogen Receptor-Mediated Targeting of the Extracellular Matrix Network in Cancer
Piperigkou, Z.;
Karamanos, N. |
Semin Cancer Biol |
2019-07-13 |
11.27 | Jul 18 |
| Breast Cancer: Occluded Role of Mitochondria N-Acetylserotonin/Melatonin Ratio in Co-Ordinating Pathophysiology
Anderson, G. |
Biochem Pharmacol |
2019-07-13 |
11.27 | Jul 18 |
| Ductal Carcinoma In Situ: To Treat or Not to Treat, That Is the Question
Seijen, M.;
Lips, E.;
Thompson, A.;
Nik-Zainal, S.;
Futreal, A.;
Et al. |
Br J Cancer |
2019-07-09 |
11.26 | Jul 11 |
| The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?
Castagnoli, L.;
Ladomery, M.;
Tagliabue, E.;
Pupa, S. |
Cancers |
2019-06-28 |
11.25 | Jul 4 |
| Emerging Role of Genomics and Cell-Free DNA in Breast Cancer
Gerratana, L.;
Davis, A.;
Shah, A.;
Lin, C.;
Corvaja, C.;
Cristofanilli, M. |
Curr Treat Options Oncol |
2019-06-29 |
11.25 | Jul 4 |
| The Emerging Role of Circular RNAs in Breast Cancer
Zhou, SY;
Chen, W;
Yang, SJ;
Xu, ZH;
Hu, JH;
Zhang, HD;
Zhong, SL;
Tang, JH |
Biosci Rep |
2019-06-25 |
11.24 | Jun 27 |
| HDL and LDL: Potential New Players in Breast Cancer Development
Cedo, L;
Reddy, ST;
Mato, E;
Blanco-Vaca, F;
Escola-Gil, JC |
J Clin Med |
2019-06-14 |
11.23 | Jun 20 |
| ESR1 Mutations: A New Biomarker in Breast Cancer
Carausu, M;
Et Al. |
Expert Rev Mol Diagn |
2019-06-12 |
11.22 | Jun 13 |
| p63 at the Crossroads between Stemness and Metastasis in Breast Cancer
Gatti, V;
Et Al. |
Int J Mol Sci |
2019-05-31 |
11.21 | Jun 6 |
| Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
Suriyamurthy, S;
Baker, D;
Dijke, PT;
Iyengar, PV |
Cancers |
2019-05-24 |
11.20 | May 30 |
| Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells
Singh, S;
Chakrabarti, R |
J Clin Med |
2019-05-09 |
11.19 | May 23 |
| Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities
Eiro, N;
Gonzalez, LO;
Fraile, M;
Cid, S;
Schneider, J;
Vizoso, FJ |
Cancers |
2019-05-13 |
11.18 | May 16 |
| Plasticity and Potency of Mammary Stem Cell Subsets during Mammary Gland Development
Lee, E;
Piranlioglu, R;
Wicha, MS;
Korkaya, H |
Int J Mol Sci |
2019-05-13 |
11.18 | May 16 |
| Mechanisms of Genomic Instability in Breast Cancer
Duijf, PHG;
Et Al. |
Trends Mol Med |
2019-05-08 |
11.17 | May 9 |
| Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics
Riobo-Del Galdo, NA;
Montero, AL;
Wertheimer, EV |
Cells |
2019-04-25 |
11.16 | May 2 |
| A Guide to Hyaluronan and Related Enzymes in Breast Cancer: Biological Significance and Diagnostic Value
Velesiotis, C;
Vasileiou, S;
Vynios, DH |
FEBS J |
2019-04-24 |
11.15 | Apr 25 |
| Current Landscape of Immunotherapy in Breast Cancer: A Review
Adams, S;
Et Al. |
JAMA Oncol |
2019-04-11 |
11.14 | Apr 18 |
| Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
Sobhani, N;
Et Al. |
Cells |
2019-04-06 |
11.13 | Apr 11 |
| Interaction of Host Immunity with HER2-Targeted Treatment and Tumor Heterogeneity in HER2-Positive Breast Cancer
Griguolo, G;
Pascual, T;
Dieci, MV;
Guarneri, V;
Prat, A |
J Immunother Cancer |
2019-03-29 |
11.12 | Apr 4 |
| Recent Advances in Understanding Tumor Stroma-Mediated Chemoresistance in Breast Cancer
Plava, J;
Cihova, M;
Burikova, M;
Matuskova, M;
Kucerova, L;
Miklikova, S |
Mol Cancer |
2019-03-30 |
11.12 | Apr 4 |
| MALAT1 Long Non-Coding RNA and Breast Cancer
Arun, G;
Spector, DL |
RNA Biol |
2019-03-22 |
11.11 | Mar 28 |
| Higher Order Genomic Organization and Epigenetic Control Maintain Cellular Identity and Prevent Breast Cancer
Fritz, AJ;
Et Al. |
Genes Chromosomes Cancer |
2019-03-15 |
11.10 | Mar 21 |
| S-Nitrosylation and Its Role in Breast Cancer Angiogenesis and Metastasis
Ehrenfeld, P;
Cordova, F;
Duran, WN;
Sanchez, FA |
Nitric Oxide |
2019-03-09 |
11.09 | Mar 14 |
| Androgen Receptor: A Promising Therapeutic Target in Breast Cancer
Vasiliou, SK;
Diamandis, EP |
Crit Rev Clin Lab Sci |
2019-03-01 |
11.08 | Mar 7 |
| Combating Breast Cancer Using Combination Therapy with 3 Phytochemicals: Piperine, Sulforaphane, and Thymoquinone
Aumeeruddy, MZ;
Mahomoodally, MF |
Cancer |
2019-02-27 |
11.07 | Feb 28 |
| Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
Mazzotta, M;
Et Al. |
J Clin Med |
2019-02-18 |
11.07 | Feb 28 |
| Emerging Role of Histone Deacetylase Inhibitors as Anti-Breast-Cancer Agents
Ediriweera, MK;
Tennekoon, KH;
Samarakoon, SR |
Drug Discov Today |
2019-02-15 |
11.06 | Feb 21 |
| Sequencing of Anthracyclines and Taxanes in Neoadjuvant and Adjuvant Therapy for Early Breast Cancer
Zaheed, M;
Wilcken, N;
Willson, ML;
O’Connell, DL;
Goodwin, A |
Cochrane Database Syst Rev |
2019-02-18 |
11.06 | Feb 21 |
| The Proliferative and Apoptotic Landscape of Basal-Like Breast Cancer
Alexandrou, S;
George, SM;
Ormandy, CJ;
Lim, E;
Oakes, SR;
Caldon, CE |
Int J Mol Sci |
2019-02-04 |
11.05 | Feb 14 |
| Patterns of Genomic Instability in Breast Cancer
Kalimutho, M;
Et Al. |
Trends Pharmacol Sci |
2019-02-05 |
11.04 | Feb 7 |
| Na+,HCO3− Cotransporter NBCn1 Accelerates Breast Carcinogenesis
Boedtkjer, E |
Cancer Metastasis Rev |
2019-02-04 |
11.04 | Feb 7 |
| Profiling of Invasive Breast Carcinoma Circulating Tumor Cells – Are We Ready for the ‘Liquid’ Revolution?
Braun, M;
Markiewicz, A;
Kordek, R;
Sądej, R;
Romańska H |
Cancers |
2019-01-25 |
11.03 | Jan 31 |
| Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Gandhi, N;
Das, GM |
Cells |
2019-01-26 |
11.03 | Jan 31 |
| Breast Cancer Treatment: A Review
Waks, AG;
Winer, EP |
JAMA |
2019-01-22 |
11.02 | Jan 24 |
| G-Protein Coupled Estrogen Receptor in Breast Cancer
Hsu, L-H;
Chu, N-M;
Lin, Y-F;
Kao, S-H |
Int J Mol Sci |
2019-01-14 |
11.01 | Jan 17 |
| RANKL/RANK/OPG System beyond Bone Remodeling: Involvement in Breast Cancer and Clinical Perspectives
Infante, M;
Fabi, A;
Cognetti, F;
Gorini, S;
Caprio, M;
Fabbri, A |
J Exp Clin Cancer Res |
2019-01-09 |
11.00 | Jan 10 |
| LncRNA Differential Expression in Breast Cancer Subtypes: What Do We Know?
Mathias, C;
Zambalde, EP;
Gradia, DF;
de Oliveira, JC;
Rask, P |
Clin Genet |
2019-01-07 |
11.00 | Jan 10 |
| Beyond 5 Years: Enduring Risk of Recurrence in Estrogen Receptor-Positive Breast Cancer
Richman, J;
Dowsett, M |
Nat Rev Clin Oncol |
2018-12-18 |
10.50 | Dec 20 |
| Hereditary Breast Cancer; Genetic Penetrance and Current Status with BRCA
Mahdavi, M;
Et Al. |
J Cell Physiol |
2018-12-14 |
10.50 | Dec 20 |
| Competing Endogenous RNA (ceRNA) Cross Talk and Language in ceRNA Regulatory Networks: A New Look at Hallmarks of Breast Cancer
Abdollahzadeh, R;
Tavakkoly-Bazzaz, J;
Et Al. |
J Cell Physiol |
2018-12-10 |
10.49 | Dec 13 |
| Molecular Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer: A Review
Pandey, K;
Moon, YW;
Et Al. |
Int J Cancer |
2018-11-26 |
10.48 | Dec 6 |
| Cancer-Associated Fibroblasts as Key Regulators of the Breast Cancer Tumor Microenvironment
Houthuijzen, JM;
Jonkers, J |
Cancer Metastasis Rev |
2018-11-21 |
10.47 | Nov 29 |
| Crosstalk between Estrogen Signaling and Breast Cancer Metabolism
Kulkoyluoglu-Cotul, E;
Arca, A;
Madak-Erdogan, Z |
Trends Endocrinol Metab |
2018-11-22 |
10.46 | Nov 22 |
| Calcium Signaling and Breast Cancer
So, CL;
Saunus, JD;
Roberts-Thomson, SJ;
Monteith, GR |
Semin Cell Dev Biol |
2018-11-16 |
10.46 | Nov 22 |
| Recent Advances in Breast Cancer Research Impacting Clinical Diagnostic Practice
McCart Reed, AE;
Kalita-de Croft, P;
Kutasovic, J;
Saunus, JM;
Lakhani, SR |
J Pathol |
2018-11-14 |
10.45 | Nov 15 |
| Key MicroRNAs in the Biology of Breast Cancer; Emerging Evidence in the Last Decade
Khordadmehr, M;
Shahbazi, R;
Ezzati, H;
Jigari-Asl, F;
Sadreddini, S;
Baradaran, B |
J Cell Physiol |
2018-11-13 |
10.45 | Nov 15 |
| Therapeutic Potential of RAS Prenylation Pharmacological Inhibitors in the Treatment of Breast Cancer, Recent Progress, and Prospective
Soleimani, A;
Amirinejad, M;
Rahsepar, S;
Vazirian, F;
Bahrami, A;
Ferns, GA;
Khazaei, M;
Avan, A;
Hassanian, SM |
J Cell Biochem |
2018-10-30 |
10.44 | Nov 8 |
| MicroRNAs and Breast Cancer Stem Cells: Potential Role in Breast Cancer Therapy
Vahidian, F;
Mohammadi, H;
Baradaran, B;
Et Al. |
J Cell Physiol |
2018-10-26 |
10.43 | Nov 1 |
| Long Non-Coding RNAs as Monitoring Tools and Therapeutic Targets in Breast Cancer
Pecero, ML;
Salvador-Bofill, J;
Molina-Pinelo, S |
Cell Oncol |
2018-10-25 |
10.43 | Nov 1 |
| miRNA and Long Non-Coding RNA: Molecular Function and Clinical Value in Breast and Ovarian Cancers
Panoutsopoulou, K;
Avgeris, M;
Scorilas, A |
Expert Rev Mol Diagn |
2018-10-19 |
10.42 | Oct 25 |
| Targeted and Immuno-Biology Driven Treatment Strategies for Triple-Negative Breast Cancer: Current Knowledge and Future Perspectives
Fremd, C;
Jaeger, D;
Schneeweiss, A |
Expert Rev Anticancer Ther |
2018-10-23 |
10.42 | Oct 25 |
| HER2 in Stemness and Epithelial-Mesenchymal Plasticity of Breast Cancer
Voutsadakis, IA |
Clin Transl Oncol |
2018-10-10 |
10.41 | Oct 18 |
| BRCA Mutations: Is Everything Said?
López-Urrutia, E;
Salazar-Rojas, V;
Brito-Elías, L;
Coca-González, M;
Silva-García, J;
Sánchez-Marín, D;
Campos-Parra, AD;
Pérez-Plasencia, C |
Breast Cancer Res Treat |
2018-10-06 |
10.40 | Oct 11 |
| Functional Role of MicroRNAs in the Progression of Breast Ductal Carcinoma In Situ
Hannafon, B;
Ding, W |
Am J Pathol |
2018-09-28 |
10.39 | Oct 4 |
| KDM5 Demethylases and Their Role in Cancer Cell Chemoresistance
Plch, J;
Hrabeta, J;
Eckschlager, T |
Int J Cancer |
2018-09-24 |
10.38 | Sep 27 |
| How Does Estrogen Work on Autophagy?
Xiang, J;
Liu, X;
Ren, J;
Chen, K;
Wang, H;
Miao, Y;
Qi, M |
Autophagy |
2018-09-13 |
10.37 | Sep 20 |
| Progress in Adjuvant Systemic Therapy for Breast Cancer
Ponde, N;
Zardavas, D;
Piccart, M |
Nat Rev Clin Oncol |
2018-09-11 |
10.36 | Sep 13 |
| WNT5A as a Therapeutic Target in Breast Cancer
Prasad, C;
Manchanda, M;
Mohapatra, P;
Andersson, T |
Cancer Metastasis Rev |
2018-08-31 |
10.35 | Sep 6 |
| Epigenomics of Mammary Gland Development
Holliday, H;
Baker, L;
Junakar, S;
Clark, S;
Swarbrick, A |
Breast Cancer Res |
2018-09-03 |
10.35 | Sep 6 |
| The Viral Approach to Breast Cancer Immunotherapy
Arab, A;
Behravan, N;
Behravan, J;
et al |
J Cell Physiol |
2018-08-26 |
10.34 | Aug 30 |
| Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers
Cheng, M;
Michalski, S;
Kommagani, R |
Int J Mol Sci |
2018-08-28 |
10.34 | Aug 30 |
| Cancer Cell Plasticity: Impact on Tumor Progression and Therapy Response
da Silva-Diz, V;
Lorenso-Sanz, L;
Bernat-Peguera, A;
Lopez-Cerda, M;
Munoz, P |
Semin Cancer Biol |
2018-08-18 |
10.33 | Aug 23 |
| Effects of Isoflavones on Breast Tissue and the Thyroid Hormone System in Humans: A Comprehensive Safety Evaluation
Huser, S;
Guth, S;
Kulling, S;
et al |
Arch Toxicol |
2018-08-21 |
10.33 | Aug 23 |
| Role of Hypoxia-Induced Exosomes in Tumor Biology
Shao, C;
Yang, F;
Miao, S;
Liu, W;
Wang, C;
Shu, Y;
Shen, H |
Mol Cancer |
2018-08-11 |
10.32 | Aug 16 |
| Is There a Role for Immunotherapy in HER2-Positive Breast Cancer?
Holgado, E;
Perez-Garcia, J;
Gion, M;
Cortes, J |
npj Breast Cancer |
2018-08-15 |
10.32 | Aug 16 |
| Advances in Targeting Epidermal Growth Factor Receptor Signaling Pathway in Mammary Cancer
Kyriakopoulou, K;
Kefali, E;
Piperigkou, Z;
Bassiony, H;
Karamanos, N |
Cell Signal |
2018-07-31 |
10.31 | Aug 9 |
| Functional Implications of Rab27 GTPases in Cancer
Li, Z;
Fang, R;
Fang, J;
He, S;
Liu, T |
Cell Commun Signal |
2018-08-06 |
10.31 | Aug 9 |
| CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
Goel, S;
DeCristo, M;
McAllister, S;
Zhao, J |
Trends Cell Biol |
2018-07-27 |
10.30 | Aug 2 |
| Breast Cancer Stem Cells: Features, Key Drivers and Treatment Options
Dittmer, J |
Semin Cancer Biol |
2018-07-27 |
10.30 | Aug 2 |
| CDKN2A/P16INK4A Variants Association with Breast Cancer and Their In-Silico Analysis
Aftab, A;
Shahzad, S;
Hussain, H;
Khan, R;
Irum, S;
Tabassum, S |
Breast Cancer |
2018-07-23 |
10.29 | Jul 26 |
| Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
Sobhani, N;
Ianza, A;
D’Angelo, A;
Generali, D;
et al |
Cells |
2018-07-15 |
10.28 | Jul 19 |
| HOXA11 Antisense Long Noncoding RNA (HOXA11-AS): A Promising lncRNA in Human Cancers
Lu, C;
Zhou, D;
Liu, X;
et al |
Cancer Med |
2018-07-10 |
10.27 | Jul 12 |
| Epithelial-to-Mesenchymal Transition and Cancer Stem Cells Contribute to Breast Cancer Heterogeneity
Hong, D;
Fritz, A;
Stein, G;
et al |
J Cell Physiol |
2018-07-03 |
10.26 | Jul 5 |
| CDK4/6 Inhibitors in Breast Cancer Therapy: Current Practice and Future Opportunities
Lynce, F;
Shajahan-Haq, A;
Swain, S |
Pharmacol Ther |
2018-06-19 |
10.25 | Jun 28 |
| Clinical and Molecular Aspects of Breast Cancer: Targets and Therapies
Godone, R;
Leitão, G;
Araújo, N;
Castelletti, C;
Lima-Filho, J;
Martins, D |
Biomed Pharmacother |
2018-06-23 |
10.25 | Jun 28 |
| Statins – a Role in Breast Cancer Therapy?
Borgquist, S;
Bjarnadottir, O;
Kimbung, S;
Ahern, T |
J Intern Med |
2018-06-20 |
10.24 | Jun 21 |
| MicroRNAs in Regulation of Triple-Negative Breast Cancer Progression
Piasecka, D;
Braun, M;
Kordek, R;
Sadej, R;
Romanska, H |
J Cancer Res Clin Oncol |
2018-06-19 |
10.24 | Jun 21 |
| The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer
Hughes, K;
Watson, CJ |
Int J Mol Sci |
2018-06-07 |
10.23 | Jun 14 |
| Basal-Like Breast Cancers: From Pathology to Biology and Back Again
Gusterson, B;
Eaves, CJ |
Stem Cell Reports |
2018-06-05 |
10.22 | Jun 7 |
| Checkpoint Blockade in the Treatment of Breast Cancer: Current Status and Future Directions
Wein, L;
Luen, S;
Savas, P;
Salgado, R;
Loi, S |
Br J Cancer |
2018-05-29 |
10.21 | May 31 |
| Androgen Blockade Based Clinical Trials Landscape in Triple Negative Breast Cancer
Shi, Y;
Yang, F;
Huang, D;
Guan, X |
Biochim Biophys Acta |
2018-05-25 |
10.21 | May 31 |
| Estrogen Receptor-Negative Progesterone Receptor-Positive Breast Cancer – “Nobody’s Land” or Just an Artifact?
Kunc, M;
Biernat, W;
Senkus-Konefka, E |
Cancer Treat Rev |
2018-05-10 |
10.20 | May 24 |
| Homologous Recombination Deficiency and Host Anti-Tumor Immunity in Triple-Negative Breast Cancer
Telli, M;
Stover, D;
et al |
Breast Cancer Res Treat |
2018-05-07 |
10.19 | May 17 |
| Applications of RNA Indexes for Precision Oncology in Breast Cancer
Ma, L;
Liang, Z;
Zhou, H;
Qu, L |
Genomics Proteomics Bioinformatics |
2018-05-09 |
10.19 | May 17 |
| Genetic Modifiers of the Breast Tumor Microenvironment
Flister, M;
Bergom, C |
Trends Cancer |
2018-05-08 |
10.18 | May 9 |
| Inflammatory Breast Cancer Biology: The Tumour Microenvironment Is Key
Lim, B;
Woodward, W;
Wang, X;
Reuben, J;
Ueno, N |
Nat Rev Cancer |
2018-04-27 |
10.17 | May 3 |
| Mechanisms of Resistance in Estrogen Receptor Positive Breast Cancer: Overcoming Resistance to Tamoxifen/Aromatase Inhibitors
Mills, J;
Rutkovsky, A;
Giordano, A |
Curr Opin Pharmacol |
2018-04-30 |
10.17 | May 3 |
| Structural Underpinnings of Oestrogen Receptor Mutations in Endocrine Therapy Resistance
Katzenellenbogen, J;
Mayne, C;
Katzenellenbogen, B;
Greene, G;
Chandarlapaty, S |
Nat Rev Cancer |
2018-04-16 |
10.16 | Apr 26 |
| Microcalcifications in Breast Cancer: From Pathophysiology to Diagnosis and Prognosis
O’Grady, S;
Morgan, M |
Biochim Biophys Acta |
2018-04-21 |
10.16 | Apr 26 |
| PARP Inhibitors in Breast Cancer: Bringing Synthetic Lethality to the Bedside
Turk, A;
Wisinski, K |
Cancer |
2018-04-16 |
10.15 | Apr 19 |
| HER2-Positive Breast Cancer: Current and New Therapeutic Strategies
Escrivá-de-Romaní, S;
Arumí, M;
Bellet, M;
Saura, C |
Breast |
2018-04-06 |
10.14 | Apr 12 |
| Cytokine-Mediated Therapeutic Resistance in Breast Cancer
Tan, C;
Hu, W;
He, Y;
Zhang, Y;
Zhang, G;
Xu, Y;
Tang, J |
Cytokine |
2018-03-30 |
10.13 | Apr 5 |
| Breast Cancer Lung Metastasis: Molecular Biology and Therapeutic Implications
Jin, L;
Han, B;
Siegel, E;
Cui, Y;
Giuliano, A;
Cui, X |
Cancer Biol Ther |
2018-03-26 |
10.12 | Mar 29 |
| Non-Angiogenic Tumors and Their Influence on Cancer Biology
Donnem, T;
Reynolds, AR;
Kuczynski, EA;
Gatter, K;
Vermeulen, PB;
Kerbel, RS;
Harris, AL;
Pezzella, F |
Nat Rev Cancer |
2018-03-22 |
10.11 | Mar 22 |
| High Mobility Group A (HMGA) Proteins: Molecular Instigators of Breast Cancer Onset and Progression
Sgarra, R;
Pegoraro, S;
Ros, G;
Penzo, C;
Chiefari, E;
Foti, D;
Brunetti, A;
Manfioletti, G |
Biochim Biophys Acta |
2018-03-06 |
10.10 | Mar 15 |
| BET Proteins in Abnormal Metabolism, Inflammation, and the Breast Cancer Microenvironment
Andrieu, GP;
Shafran, JS;
Deeney, JT;
Bharadwaj, KR;
Rangarajan, A;
Denis, GV |
J Leukoc Biol |
2018-03-01 |
10.09 | Mar 8 |
| A Novel Functional Crosstalk between DDR1 and the IGF Axis and Its Relevance for Breast Cancer
Belfiore, A;
Malaguarnera, R;
Nicolosi, ML;
Lappano, R;
Ragusa, M;
Morrione, A;
Vella, V |
Cell Adh Migr |
2018-02-28 |
10.08 | Mar 1 |
| Receptor Tyrosine Kinases (RTKs) in Breast Cancer: Signaling, Therapeutic Implications and Challenges
Butti, R;
Das, S;
Gunasekaran, VP;
Yadav, AS;
Kumar, D;
Kundu, GC |
Mol Cancer |
2018-02-19 |
10.07 | Feb 22 |
| Checkpoint Inhibitors in Triple-Negative Breast Cancer (TNBC): Where to Go from Here
Kwa, MJ;
Adams, S |
Cancer |
2018-02-09 |
10.07 | Feb 22 |
| Role of Autophagy in Breast Cancer and Breast Cancer Stem Cells
Han, Y;
Fan, S;
Qin, T;
Yang, J;
Sun, Y;
Lu, Y;
Mao, J;
Li, L |
Int J Oncol |
2018-02-08 |
10.06 | Feb 15 |
| Multifaceted Roles of Interleukin-6 in Adipocyte–Breast Cancer Cell Interaction
Gyamfi, J;
Eom, M;
Koo, JS;
Choi, J |
Transl Oncol |
2018-01-30 |
10.05 | Feb 8 |
| Anti-Insulin-Like Growth Factor Therapy in Breast Cancer
Yee, D |
J Mol Endocrinol |
2018-01-29 |
10.04 | Feb 1 |
| Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer
Yang, J;
Harris, AL;
Davidoff, AM |
Int J Mol Sci |
2018-01-13 |
10.03 | Jan 25 |
| Using Gene Expression Data to Direct Breast Cancer Therapy: Evidence from a Preclinical Trial
Reaz, S;
Tamkus, D;
Andrechek, ER |
J Mol Med (Berl) |
2018-01-08 |
10.02 | Jan 18 |
| Breast Cancer Bone Metastases: Pathogenesis and Therapeutic Targets
Brook, N;
Brook, E;
Dharmarajan, A;
Dass, CR;
Chan, A |
Int J Biochem Cell Biol |
2018-01-04 |
10.01 | Jan 11 |
| Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer
Halvaei, S;
Daryani, S;
Eslami-S, Z;
Samadi, T;
Jafarbeik-Iravani, N;
Bakhshayesh, TO;
Majidzadeh-A, K;
Esmaeili, R |
Mol Ther Nucleic Acids |
2017-12-21 |
10.00 | Jan 4 |
| RANKL and RANK: From Mammalian Physiology to Cancer Treatment
Rao, S;
Cronin, SJF;
Sigl, V;
Penninger, JM |
Trends Cell Biol |
2017-12-11 |
9.49 | Dec 14 |
| Epithelial Plasticity in the Mammary Gland
Seldin, L;
Le Guelte, A;
Macara, IG |
Curr Opin Cell Biol |
2017-12-09 |
9.49 | Dec 14 |
| Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models
VanderSluis, L;
Mazurak, VC;
Damaraju, S;
Field, CJ |
Int J Mol Sci |
2017-12-04 |
9.48 | Dec 7 |
| The Dual Regulatory Role of MiR-181a in Breast Cancer
Yang, C;
Tabatabaei, SN;
Ruan, X;
Hardy, P |
Cell Physiol Biochem |
2017-11-24 |
9.47 | Nov 30 |
| Targeting Protein Quality Control Pathways in Breast Cancer
Sannino, S;
Brodsky, JL |
BMC Biol |
2017-11-16 |
9.46 | Nov 23 |
| Extranuclear Signaling by Sex Steroid Receptors and Clinical Implications in Breast Cancer
Boonyaratanakornkit, V;
Hamilton, N;
Márquez-Garbán, DC;
Pateetin, P;
McGowan, EM;
Pietras, RJ |
Mol Cell Endocrinol |
2017-11-14 |
9.46 | Nov 23 |
| Implications of Aging and the Endoplasmic Reticulum Unfolded Protein Response on the Molecular Modality of Breast Cancer
Minakshi, R;
Rahman, S;
Jan, AT;
Archana, A;
Kim, J |
Exp Mol Med |
2017-11-10 |
9.45 | Nov 16 |
| Triple-Negative Breast Cancer, Stem Cells, and African Ancestry
Jiagge, E;
Chitale, D;
Newman, LA |
Am J Pathol |
2017-11-11 |
9.45 | Nov 16 |
| Recent Advances in Comprehending the Signaling Pathways Involved in the Progression of Breast Cancer
Nicolini, A;
Ferrari, P;
Diodati, L;
Carpi, A |
Int J Mol Sci |
2017-11-03 |
9.44 | Nov 9 |
| PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer
Geenen, JJJ;
Linn, SC;
Beijnen, JH;
Schellens, JHM |
Clin Pharmacokinet |
2017-10-23 |
9.43 | Nov 2 |
| Kinesin Superfamily: Roles in Breast Cancer, Patient Prognosis and Therapeutics
Lucanus, AJ;
Yip, GW |
Oncogene |
2017-10-23 |
9.42 | Oct 26 |
| CDK4/6 Blockade in Breast Cancer: Current Experience and Future Perspectives
Zardavas, D;
Pondé, N;
Tryfonidis, K |
Expert Opin Investig Drugs |
2017-10-13 |
9.41 | Oct 19 |
| Targeting Triple Negative Breast Cancer with Histone Deacetylase Inhibitors
Fedele, P;
Orlando, L;
Cinieri, S |
Expert Opin Investig Drugs |
2017-10-08 |
9.40 | Oct 12 |
| The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
Fedele, M;
Cerchia, L;
Chiappetta, G |
Genes (Basel) |
2017-09-30 |
9.39 | Oct 5 |
| Fatty Acid Synthase (FASN) as a Therapeutic Target in Breast Cancer
Menendez, JA;
Lupu, R |
Expert Opin Ther Targets |
2017-09-21 |
9.38 | Sep 28 |
| Obesity and Breast Cancer – Role of Estrogens and the Molecular Underpinnings of Aromatase Regulation in Breast Adipose Tissue
Gérard, C;
Brown, KA |
Mol Cell Endocrinol |
2017-09-15 |
9.37 | Sep 21 |
| Prognostic and Predictive Biomarkers in Breast Cancer: Past, Present and Future
Nicolini, A;
Ferrari, P;
Duffy, MJ |
Semin Cancer Biol |
2017-09-04 |
9.36 | Sep 14 |
| DNA Repair-Related Functional Assays for the Classification of BRCA1 and BRCA2 Variants: A Critical Review and Needs Assessment
Toland, AE;
Andreassen, PR |
J Med Genet |
2017-09-02 |
9.35 | Sep 7 |
| Circulating MicroRNAs in Breast Cancer: Novel Diagnostic and Prognostic Biomarkers
Hamam, R;
Hamam, D;
Alsaleh, KA;
Kassem, M;
Zaher, W;
Alfayez, M;
Aldahmash, A;
Alajez, NM |
Cell Death Dis |
2017-09-07 |
9.35 | Sep 7 |
| Estrogen and Progesterone Signaling in the Normal Breast and Its Implications for Cancer Development
Hilton, HN;
Clarke, CL;
Graham, JD |
Mol Cell Endocrinol |
2017-08-26 |
9.34 | Aug 31 |
| MUC1 Story: Great Expectations, Disappointments and the Renaissance
Rubtsov, MA;
Syrkina, MS;
Vassetzky, YS |
Curr Med Chem |
2017-08-17 |
9.33 | Aug 24 |
| Tumor-Derived Exosomes: Potential Biomarker or Therapeutic Target in Breast Cancer?
Hesari, A;
Moghadam, SAG;
Siasi, A;
Rahmani, M;
Behboodi, N;
Rastgar-Moghadam, A;
Ferns, GA;
Ghasemi, F;
Avan, A |
J Cell Biochem |
2017-08-18 |
9.33 | Aug 24 |
| Nanocarrier Based Approaches for Targeting Breast Cancer Stem Cells
Pindiprolu, SKSS;
Krishnamurthy, PT;
Chintamaneni, PK;
Karri, VVSR |
Artif Cells Nanomed Biotechnol |
2017-08-21 |
9.33 | Aug 24 |
| MELK: A Potential Novel Therapeutic Target for TNBC and Other Aggressive Malignancies
Pitner, MK;
Taliaferro, JM;
Dalby, KN;
Bartholomeusz, C |
Expert Opin Ther Targets |
2017-08-16 |
9.32 | Aug 17 |
| Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1
Bertucci, F;
Gonçalves, A |
Curr Oncol Rep |
2017-08-10 |
9.32 | Aug 17 |
| Aberrantly miRNA Promoter Methylation and EMT-Involving miRNAs in Breast Cancer Metastasis: Diagnosis and Therapeutic Implications
Zare, M;
Bastami, M;
Solali, S;
Alivand, M |
J Cell Physiol |
2017-08-03 |
9.31 | Aug 10 |
| MACF1, a Novel Potential Target in Cancer
Miao, Z;
Ali, A;
Hu, L;
Zhao, F;
Yin, C;
Chen, C;
Yang, T;
Qian, A |
Cancer Sci |
2017-08-07 |
9.31 | Aug 10 |
| Altered Glutamine Metabolism in Breast Cancer; Subtype Dependencies and Alternative Adaptations
El Ansari, R;
McIntyre, A;
Craze, ML;
Ellis, IO;
Rakha, EA;
Green, AR |
Histopathology |
2017-08-03 |
9.31 | Aug 10 |
| Breast Cancer Complexity: Implications of Intratumoral Heterogeneity in Clinical Management
Haynes, B;
Sarma, A;
Nangia-Makker, P;
Shekhar, MP |
Cancer Metastasis Rev |
2017-07-27 |
9.30 | Aug 3 |
| Tumor Organoids as a Pre-Clinical Cancer Model for Drug Discovery
Weeber, F;
Ooft, SN;
Dijkstra, KK;
Voest, EE |
Cell Chem Biol |
2017-07-27 |
9.30 | Aug 3 |
| Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research
Mardamshina, M;
Geiger, T |
Am J Pathol |
2017-07-20 |
9.29 | Jul 27 |
| Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Palbociclib, Ribociclib, and Abemaciclib
Kwapisz D |
Breast Cancer Res Treat |
2017-07-24 |
9.29 | Jul 27 |
| Treating Breast Cancer with Cell-Based Approaches: An Overview
Gallo, S;
Sangiolo, D;
Carnevale Schianca, F;
Aglietta, M;
Montemurro, F |
Expert Opin Biol Ther |
2017-07-20 |
9.29 | Jul 27 |
| Current Trials to Reduce Surgical Intervention in Ductal Carcinoma In Situ of the Breast: Critical Review
Toss M;
Miligy I;
Thompson AM;
Khout H;
Green AR;
Ellis IO;
Rakha EA |
Breast |
2017-07-22 |
9.29 | Jul 27 |
| Breast Cancer Stem Cells as Last Soldiers Eluding Therapeutic Burn: A Hard Nut to Crack
Nilendu, P;
Kumar, A;
Kumar, A;
Pal, JK;
Sharma, NK |
Int J Cancer |
2017-07-19 |
9.28 | Jul 20 |
| Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
Spring, LM;
Zangardi, ML;
Moy, B;
Bardia, A |
Oncologist |
2017-07-13 |
9.28 | Jul 20 |
| Possible Roles for Glucocorticoid Signaling in Breast Cancer
McNamara, KM;
Kannai, A;
Sasano, H |
Mol Cell Endocrinol |
2017-07-04 |
9.27 | Jul 13 |
| Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications
Sempere, LF;
Keto, J;
Fabbri, M |
Cancers |
2017-07-06 |
9.26 | Jul 6 |
| MUC1 Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer
Merikhian, P;
Ghadirian, R;
Farahmand, L;
Mansouri, S;
Majidzadeh-A, K |
Expert Rev Anticancer Ther |
2017-06-21 |
9.25 | Jun 29 |
| Viral Gene Therapy for Breast Cancer: Progress and Challenges
Asad, AS;
Moreno Ayala, MA;
Gottardo, MF;
Zuccato, C;
Nicola Candia, AJ;
Zanetti, FA;
Seilicovich, A;
Candolfi, M |
Expert Opin Biol Ther |
2017-06-12 |
9.24 | Jun 22 |
| 27-Hydroxycholesterol: A Novel Player in Molecular Carcinogenesis of Breast and Prostate Cancer
Marwarha, G;
Raza, S;
Hammer, K;
Ghribi, O |
Chem Phys Lipids |
2017-06-03 |
9.23 | Jun 15 |
| Inflammatory Breast Cancer: A Model for Investigating Cluster-Based Dissemination
Jolly, MH;
Boareto, M;
Debeb, BG;
Aceto, N;
Farach-Carson, MC;
Woodward, WA;
Levine, H |
npj Breast Cancer |
2017-06-06 |
9.22 | Jun 8 |
| Clinical Utility of Gene-Expression Signatures in Early Stage Breast Cancer
Kwa, M;
Makris, A;
Esteva, FJ |
Nat Rev Clin Oncol |
2017-05-31 |
9.21 | Jun 1 |
| Prolactin Receptor Targeting in Breast and Prostate Cancers: New Insights into an Old Challenge
Goffin, V |
Pharmacol Ther |
2017-05-23 |
9.21 | Jun 1 |
| Breast Cancer Metastasis: Putative Therapeutic Role of Vascular Cell Adhesion Molecule-1
Sharma, R;
Sharma, R;
Pal Khaket, T;
Dutta, C;
Chakraborty, B;
Mukherjee, TK |
Cell Oncol |
2017-05-22 |
9.20 | May 24 |
| The Role of TGF-β and Its Crosstalk with RAC1/RAC1b Signaling in Breast and Pancreas Carcinoma
Melzer C;
Hass, R;
von der Ohe, J;
Lehnert, H;
Ungefroren, H |
Cell Commun Signal |
2017-05-12 |
9.19 | May 18 |
| The Therapeutic Potential of PI3K/Akt/MTOR Inhibitors in Breast Cancer: Rational and Progress
Bahrami, A;
Khazaei, M;
Shahidsales, S;
Hassanian, SM;
Hasanzadeh, M;
Maftouh, M;
Ferns, GA;
Avan, A |
J Cell Biochem |
2017-05-17 |
9.19 | May 18 |
| Mammary Stem Cells: Premise, Properties, and Perspectives
Lloyd-Lewis, B;
Harris, OB;
Watson, CJ;
Davis, FM |
Trends Cell Biol |
2017-05-06 |
9.18 | May 11 |
| Immunotherapy for the Treatment of Breast Cancer
Moreno Ayala, MA;
Gottardo, MF;
Asad, AS;
Zuccato, C;
Nicola, A;
Seilicovich, A;
Candolfi, M |
Expert Opin Biol Ther |
2017-04-27 |
9.17 | May 4 |
| HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance
Nami, B;
Wang, Z |
Cancers |
2017-04-26 |
9.16 | Apr 27 |
| Regulation of Breast Cancer Progression by Extracellular Matrix Mechanics: Insights from 3D Culture Models
Lee, JY;
Chaudhuri, O |
ACS Biomater Sci Eng |
2017-04-07 |
9.16 | Apr 27 |
| The Most Prevalent Side Effects of Pegylated Liposomal Doxorubicin Monotherapy in Women with Metastatic Breast Cancer: A Systematic Review of Clinical Trials
Ansari, L;
Shiehzadeh, F;
Taherzadeh, Z;
Nikoofal-Sahlabadi, S;
Momtazi-Borojeni, AA;
Sahebkar, A;
Eslami, S |
Cancer Gene Ther |
2017-04-14 |
9.15 | Apr 20 |
| Cell State Plasticity, Stem Cells, EMT, and the Generation of Intra-Tumoral Heterogeneity
None |
NPJ Breast Cancer |
2017-04-19 |
9.15 | Apr 20 |
| Role of Adenosine Signaling in the Pathogenesis of Breast Cancer
Bahreyni, A;
Samani, SS;
Rahmani, F;
Behnam-Rassouli, R;
Khazaei, M;
Ryzhikov, M;
Parizadeh, MR;
Avan, A;
Hassanian, SM |
J Cell Physiol |
2017-04-06 |
9.14 | Apr 13 |
| Wnt Signaling in Triple-Negative Breast Cancer
Pohl SG;
Brook, N;
Agostino, M;
Arfuso, F;
Kumar, AP;
Dharmarajan, A |
Oncogenesis |
2017-04-03 |
9.13 | Apr 6 |
| The Opportunity of Precision Medicine for Breast Cancer with Context-Sensitive Tumor Suppressor Maspin
Bernardo, MM;
Dzinic, SH;
Matta, MJ;
Dean, I;
Saker, L;
Sheng, S |
J Cell Biochem |
2017-03-21 |
9.13 | Apr 6 |
| Mechanisms Governing Metastatic Dormancy in Breast Cancer
Dittmer, J |
Semin Cancer Biol |
2017-03-23 |
9.12 | Mar 30 |
| Mechanisms of Resistance to Selective Estrogen Receptor Down-Regulator in Metastatic Breast Cancer
Huang, D;
Yang, F;
Wang, Y;
Guan, X |
Biochim Biophys Acta |
2017-03-23 |
9.12 | Mar 30 |
| Non-Autonomous Cell Proliferation in the Mammary Gland and Cancer
Weber, RJ;
Desai, TA;
Gartner, ZJ |
Curr Opin Cell Biol |
2017-03-14 |
9.11 | Mar 23 |
| FOXC1: An Emerging Marker and Therapeutic Target for Cancer
B, Han;
N, Bhowmick;
Y, Qu;
S, Chung;
AE, Giuliano;
X, Cui |
Oncogene |
2017-03-13 |
9.10 | Mar 16 |
| Role of Runx2 in Breast Cancer-Mediated Bone Metastasis
Vishal, M;
Swetha, R;
Thejaswini, G;
Arumugam, B;
Selvamurugan, N |
Int J Biol Macromol |
2017-03-04 |
9.09 | Mar 9 |
| Modulation of Ras/ERK and Phosphoinositide Signaling by Long-Chain N-3 PUFA in Breast Cancer and Their Potential Complementary Role in Combination with Targeted Drugs
Serini, S;
Calviello, G |
Nutrients |
2017-02-23 |
9.08 | Mar 2 |
| From Basic Apoptosis Discoveries to Advanced Selective BCL-2 Family Inhibitors
Ashkenazi, A;
Fairbrother, WJ;
Leverson, JD;
Souers, AJ |
Nat Rev Drug Discov |
2017-02-17 |
9.07 | Feb 23 |
| PI3K-AKT-mTOR Inhibitors in Breast Cancers: From Tumor Cell Signaling to Clinical Trials
Nandini, D;
Pradip, D;
Brian, LJ |
Pharmacol Ther |
2017-02-16 |
9.07 | Feb 23 |
| Hormonally Up-Regulated Neu-Associated Kinase: A Novel Target for Breast Cancer Progression
Zambrano, JN;
Neely, BA;
Yeh, ES |
Pharmacol Res |
2017-02-09 |
9.06 | Feb 16 |
| Long Non-Coding RNAs in Triple Negative Breast Cancer
Wang, Q;
Gao, S;
Li, H;
Lv, M;
Lu, C |
J Cell Physiol |
2017-01-31 |
9.05 | Feb 9 |
| Oncogenic Mechanisms of Lin28 in Breast Cancer: New Functions and Therapeutic Opportunities
Xiong, H;
Zhao, W;
Wang, J;
Seifer, BJ;
Ye, C;
Chen, Y;
Jia, Y;
Chen, C;
Shen, J;
Wang, L;
Sui, X;
Zhou, J |
Oncotarget |
2017-01-29 |
9.04 | Feb 2 |
| The Role of MDM2 and MDM4 in Breast Cancer Development and Prevention
Haupt, S;
Vijayakumaran, R;
Panimaya, J;
Burgess, A;
Lim, E;
Haupt, Y |
J Mol Cell Biol |
2017-01-17 |
9.03 | Jan 26 |
| Patient-Derived Xenograft (PDX) Models in Basic and Translational Breast Cancer Research
Dobrolecki, LE;
Airhart, SD;
Alferez, DG;
Aparicio, S;
Behbod, F;
Bentires-Alj, M;
Brisken, C;
Bult, CJ;
Cai, S;
Clarke, RB;
Dowst, H;
Ellis, MJ;
Gonzalez-Suarez, E;
Iggo, RD;
Kabos, P;
Li, S;
Lindeman, GJ;
Marangoni, E;
McCoy, A;
Meric-Bernstam, F;
Piwnica-Worms, H;
Poupon, MF;
Reis-Filho, J;
Sartorius, CA;
Scabia, V;
Sflomos, GJ;
Tu, Y;
Vaillant, F;
Visvader, JE;
Welm, A;
Wicha, MS;
Lewis, MT |
Cancer Metastasis Rev |
2016-12-27 |
9.03 | Jan 26 |
| Mammary Stem Cells: Angels or Demons in Mammary Gland?
Chen, X;
Liu, Q;
Song, E |
Signal Transduct Target Ther |
2017-01-13 |
9.02 | Jan 19 |
| Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
Toss, A;
Venturelli, M;
Peterle, C;
Piacentini, F;
Cascinu, S;
Cortesi, L |
Int J Mol Sci |
2017-01-04 |
9.01 | Jan 12 |
| Hypoxia‐Inducible Factors: Coupling Glucose Metabolism and Redox Regulation with Induction of the Breast Cancer Stem Cell Phenotype
Semenza, GL |
EMBO J |
2016-12-22 |
9.00 | Jan 5 |
| Cellular and Molecular Mechanism Underlying Alcohol-Induced Aggressiveness of Breast Cancer
Wang, Y;
Xu, M;
Ke, ZJ;
Luo, J |
Pharmacol Res |
2016-12-08 |
8.49 | Dec 15 |
| From Transformation to Metastasis: Deconstructing the Extracellular Matrix in Breast Cancer
Kaushik, S;
Pickup, MW;
Weaver, VM |
Cancer Metastasis Rev |
2016-12-02 |
8.48 | Dec 8 |
| The Role of HER2, EGFR, and Other Receptor Tyrosine Kinases in Breast Cancer
Hsu, JL;
Hung, MC |
Cancer Metastasis Rev |
2016-12-02 |
8.48 | Dec 8 |
| Inflammation, Dysregulated Metabolism and Aromatase in Obesity and Breast Cancer
Zahid, H;
Simpson, ER;
Brown, KA |
Curr Opin Pharmacol |
2016-11-19 |
8.47 | Dec 1 |
| Molecular Mechanisms of Asymmetric Divisions in Mammary Stem Cells
Santoro, A;
Vlachou, T;
Carminati, M;
Pelicci, PG;
Mapelli, M |
EMBO Rep |
2016-11-21 |
8.46 | Nov 24 |
| Identifying Progression Predictors of Breast Ductal Carcinoma In Situ
Yeong, J;
Thike, AA;
Tan, PH;
Iqbal, J |
J Clin Pathol |
2016-11-18 |
8.46 | Nov 24 |
| PIN1 in Breast Development and Cancer: A Clinical Perspective
Rustighi, A;
Zannini, A;
Campaner, E;
Ciani, Y;
Piazza, S;
Del Sal, G |
Cell Death Differ |
2016-11-11 |
8.45 | Nov 17 |
| Epithelial Plasticity during Human Breast Morphogenesis and Cancer Progression
Ingthorsson, S;
Briem, E;
Bergthorsson, JT;
Gudjonsson, T |
J Mammary Gland Biol Neoplasia |
2016-11-04 |
8.44 | Nov 10 |
| Multiple Functions of USP18
Honke, N;
Shaabani, N;
Zhang, D-E;
Hardt, C;
Lang, KS |
Cell Death Dis |
2016-11-03 |
8.43 | Nov 3 |
| Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack
Bulfoni, M;
Turetta, M;
Del Ben, F;
Di Loreto, C;
Beltrami, AP;
Cesselli, D |
Int J Mol Sci |
2017-10-24 |
8.42 | Oct 27 |
| Palmitoylation: A Protein S-Acylation with Implications for Breast Cancer
Anderson, AM;
Ragan, MA |
NPJ Breast Cancer |
2016-10-19 |
8.41 | Oct 20 |
| Lapatinib Resistance in HER2+ Cancers: Latest Findings and New Concepts on Molecular Mechanisms
Shi, H;
Zhang, W;
Zhi, Q;
Jiang, M |
Tumor Biol |
2016-10-10 |
8.40 | Oct 13 |
| Alternative Splicing and Cell Survival: From Tissue Homeostasis to Disease
Paronetto, MP;
Passacantilli, I;
Sette, C |
Cell Death Differ |
2016-09-30 |
8.39 | Oct 6 |
| Maintaining Cell Identity: PRC2-Mediated Regulation of Transcription and Cancer
Comet, I;
Riising, EM;
Leblanc, B;
Helin, K |
Nat Rev Cancer |
2016-09-23 |
8.38 | Sep 29 |
| Altered Metabolite Levels in Cancer: Implications for Tumor Biology and Cancer Therapy
Sullivan, LB;
Gui, DY;
Heiden, MG |
Nat Rev Cancer |
2016-09-23 |
8.38 | Sep 29 |
| Tackling Breast Cancer Chemoresistance with Nano-Formulated SiRNA
Jones, SK;
Merke, OM |
Gene Ther |
2016-09-20 |
8.37 | Sep 22 |
| Targeting Cancer Stem Cells and Signaling Pathways by Phytochemicals: Novel Approach for Breast Cancer Therapy
Dandawate, PR;
Subramaniam, D;
Jensen, RA;
Anant. S |
Semin Cancer Biol |
2016-09-05 |
8.36 | Sep 15 |
| On Metabolic Reprograming and Tumor Biology: A Comprehensive Survey of Metabolism in Breast Cancer
Penkert, J;
Ripperger, T;
Schieck, M;
Schlegelberger, B;
Steinemann, D;
Illig, T |
Oncotarget |
2016-08-31 |
8.35 | Sep 8 |
| The Metabolic Fate of Acetate in Cancer
Schug, ZT;
Voorde, JV;
Gottlieb, E |
Nat Rev Cancer |
2016-08-26 |
8.34 | Sep 1 |
| Oncogenic and Tumor-Suppressive Mouse Models for Breast Cancer Engaging HER2/Neu
Fry EA;
Taneja P;
Inoue K |
Int J Cancer |
2016-08-23 |
8.33 | Aug 25 |
| Breast Cancer Stem Cell: The Roles and Therapeutic Implications
Yang, F;
Xu, J;
Tang, L;
Guan, X |
Cell Mol Life Sci |
2016-08-16 |
8.32 | Aug 18 |
| Breast Cancer Cells Alter the Dynamics of Stromal Fibronectin-Collagen Interactions
Wang, K;
Wu, F;
Seo, BR;
Fischbach C;
Chen, W;
Hsu, L;
Gourdon, D |
Matrix Biol |
2016-08-05 |
8.31 | Aug 11 |
| miRNAs-Mediated Cisplatin Resistance in Breast Cancer
Chen, X;
Lu, P;
Wu, Y;
Wang, DD;
Zhou, S;
Yang, SJ;
Shen, HY;
Zhang, XH;
Zhao, JH;
Tang, JH |
Tumour Biol |
2016-07-22 |
8.30 | Aug 3 |
| Improving Early Diagnosis of Symptomatic Cancer
Hamilton, W;
Walter, FM;
Rubin, G;
Neal, RD |
Nat Rev Clin Oncol |
2016-07-26 |
8.29 | Jul 28 |
| Recent Trends in MicroRNA Research into Breast Cancer with Particular Focus on the Associations between MicroRNAs and Intrinsic Subtypes
Kurozumi, S;
Yamaguchi, Y;
Kurosumi, M;
Ohira, M;
Matsumoto, H;
Horiguchi, J |
J Hum Genet |
2016-07-21 |
8.28 | Jul 21 |
| The Anti-Metastatic Micro-Environment of the Bone: Importance of Osteocyte Cx43 Hemichannels
Bultynck, G |
Biochim Biophys Acta |
2016-07-08 |
8.27 | Jul 14 |
| Multifaceted Breast Cancer: The Molecular Connection with Obesity
Antonia, F;
Serena, R;
Soumaya, K;
Antonietta, R;
Antonella, P;
Pietro, F;
Antonio, G;
Angelina, DC;
Marina, DD |
J Cell Physiol |
2016-07-01 |
8.26 | Jun 7 |
| CDK4/6 Inhibitors for the Treatment of Advanced Hormone Receptor Positive Breast Cancer and Beyond: 2016 Update
O’Suillivan, CC |
Expert Opin Pharmacother |
2016-06-27 |
8.25 | Jun 30 |
| Mesenchymal Tumors of the Breast and Their Mimics: A Review with Approach to Diagnosis
Cheah, AL;
Billings, SD;
Rowe, JJ |
Pathology |
2016-06-15 |
8.24 | Jun 24 |
| ROS Homeostasis and Metabolism: A Dangerous Liaison in Cancer Cells
Panieri, E;
Santoro, MM |
Eur J Cancer |
2016-06-09 |
8.23 | Jun 16 |
| Binuclear Cells in the Lactating Mammary Gland: New Insights on an Old Concept?
Smith, GH |
J Mammary Gland Biol Neoplasia |
2016-06-02 |
8.22 | Jun 9 |
| Ki67, PCNA, and MCM Proteins: Markers of Proliferation in the Diagnosis of Breast Cancer
Juríková, M;
Danihel, L;
Polák, Š;
Varga, I |
Acta Histochem |
2016-05-28 |
8.21 | Jun 2 |
| Bone Metastasis: The Importance of the Neighbourhood
Croucher, PI; McDonald, MM; Martin, TJ |
Nat Rev Cancer |
2016-05-25 |
8.20 | May 26 |
| Triple-Negative Breast Cancer: Challenges and Opportunities of a Heterogeneous Disease
Bianchini, G; Balko, JM; Mayer, IA; Sanders, ME; Gianni, L |
Nat Rev Clin Oncol |
2016-05-17 |
8.19 | May 19 |
| Crosstalk between TGF-β Signaling and miRNAs in Breast Cancer Metastasis
Chen, W; Zhou, S; Mao, L; Zhang, H; Sun, D; Zhang, J; Li, J; Tang, JH |
Tumour Biol |
2016-05-06 |
8.18 | May 12 |
| The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer
Kwa, M; Plottel, CS; Blaser, MJ; Adams, S |
J Natl Cancer Inst |
2016-04-22 |
8.17 | May 5 |
| The G Protein-Coupled Estrogen Receptor as a Modulator of Neoplastic Transformation
Jacenik, D; Cygankiewicz, AI; Krajewska, WM |
Mol Cell Endocrinol |
2016-04-20 |
8.16 | Apr 28 |
| Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future
DiPippo, AJ; Patel, NK; Barnett, CM |
Pharmacotherapy |
2016/04/18 |
8.15 | Apr 21 |
| Osteoprotegerin Rich Tumor Microenvironment: Implications in Breast Cancer
Goswami, S; Sharma-Walia, N |
Oncotarget |
2016-04-08 |
8.14 | Apr 14 |
| Translating Neoadjuvant Therapy into Survival Benefits: One Size Does Not Fit All
Mattos-Arruda, LD; Shen, R; Reis-Filho, JS; Cortés, J |
Nat Rev Clin Oncol |
2016-03-22 |
8.12 | Mar 31 |
| Treating Cancer with Selective CDK4/6 Inhibitors
O’Leary, B; Finn, RS & Turner, NC |
Nat Rev Clin Oncol |
2016-03-31 |
8.12 | Mar 31 |
| Tracking Metastatic Breast Cancer: The Future of Biology in Biosensors
Lim, YC; Wiegmans, AP |
Med Oncol |
2016-03-19 |
8.11 | Mar 24 |
| Developmental Signaling Pathways Regulating Mammary Stem Cells and Contributing to the Etiology of Triple-Negative Breast Cancer
Rangel, MC; Bertolette, D; Castro, NP; Klauzinska, M; Cuttitta, F; Salomon, DS |
Breast Cancer Res Treat |
2016-03-11 |
8.10 | Mar 17 |
| Breast Cancer Stem Cells Programs: Enter the (Non)-Code
Salvador, MA; Birnbaum, D; Charafe-Jauffret, E; Ginestier, C |
Brief Funct Genomics |
2016-03-08 |
8.09 | Mar 10 |
| Targeting the RB-E2F Pathway in Breast Cancer
Johnson, J; Thijssen, B; McDermott, U; Garnett, M; Wessels, LFA; & Bernards, R |
Oncogene |
2016-02-29 |
8.08 | Mar 3 |
| Lipid-Sensors, Enigmatic-Orphan and Orphan Nuclear Receptors as Therapeutic Targets in Breast-Cancer
Garattini, E; Bolis, M; Gianni, M; Paroni, G; Fratelli, M; Terao, M |
Oncotarget |
2016-02-15 |
8.07 | Feb 25 |
| Connexin 43, Breast Cancer Tumor Suppressor: Missed Connections?
Grek, CL; Rhett, JM; Bruce, JS; Ghatnekar, GS; Yeh, ES |
Cancer Lett |
2016-02-13 |
8.06 | Feb 18 |
| Etirinotecan Pegol for the Treatment of Breast Cancer
Lopez-Miranda, E; Cortes, J |
Expert Opin Pharmacother |
2016-02-16 |
8.06 | Feb 18 |
| Biomarkers of Residual Disease after Neoadjuvant Therapy for Breast Cancer
Penault-Llorca, F; Radosevic-Robin, N |
Nat Rev Clin Oncol |
2016-02-09 |
8.05 | Feb 11 |
| Targeting the Cyclin-Dependent Kinases (CDK) 4/6 in Estrogen Receptor-Positive Breast Cancers
Finn, RS; Aleshin, A; Slamon, DJ |
Breast Cancer Res |
2016-02-09 |
8.05 | Feb 11 |
| Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers
Musolino, A; Boggiani, D; Sikokis, A; Rimanti, A; Pellegrino, B; Vattiato, R; Sgargi, P; Falcini, F; Caminiti, C; Michiara, M; Leonardi, F |
Cancer Treat Rev |
2016-02-01 |
8.04 | Feb 4 |
| Epigenomic Regulation of Oncogenesis by Chromatin Remodeling
Kumar, R; Li, DQ; Müller, S; Knapp, S |
Oncogene |
2016-01-25 |
8.03 | Jan 28 |
| BRCAness Revisited
Lord, CJ; Ashworth, A |
Nat Rev Cancer |
2016-01-18 |
8.02 | Jan 21 |
| Tumor-Associated Macrophages: Unwitting Accomplices in Breast Cancer Malignancy
Williams, CB; Yeh, ES; & Soloff, AC |
npj Breast Cancer |
2016-01-20 |
8.02 | Jan 21 |
| Gene-Environment Interaction and Risk of Breast Cancer
Rudolph, A; Chang-Claude, J; Schmidt, MK |
Br J Cancer |
2016-01-12 |
8.01 | Jan 14 |
| Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis
Cox, TR; Gartland, A; Erler, JT |
Cancer Res |
2016-01-05 |
8.00 | Jan 7 |
| 3D Scaffolds in Breast Cancer Research
Rijal, G; Li, W |
Biomaterials |
2015-12-20 |
8.00 | Jan 7 |
| Clinical Relevance of Host Immunity in Breast Cancer: From TILs to the Clinic
Savas, P; Salgado, R; Denkert, C; Sotiriou, C; Darcy, PK; Smyth, MJ; Loi, S |
Nat Rev Clin Oncol |
2015-12-15 |
7.49 | Dec 17 |
| The Roles and Therapeutic Potential of Cyclin-Dependent Kinases (CDKs) in Sarcoma
Liao, Y; Feng, Y; Shen, J; Hornicek, FJ; Duan, Z |
Cancer Metastasis Rev |
2015-12-15 |
7.49 | Dec 17 |
| The Role of Cancer-Associated Fibroblasts in Breast Cancer Pathobiology
Jung, YY; Kim, HM; Koo, JS |
Histol Histopathol |
2015-12-02 |
7.48 | Dec 10 |
| Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy
Koren, S; Bentires-Alj, M |
Mol Cell |
2015-11-19 |
7.47 | Dec 3 |
| Developmental Insights into Breast Cancer Intratumoral Heterogeneity
Zhang, M; Rosen, J |
Trends Cancer |
2015-11-24 |
7.47 | Dec 3 |
| The Extracellular Matrix in Breast Cancer Predicts Prognosis through Composition, Splicing and Crosslinking
Robertson, C |
Exp Cell Res |
2015-511-17 |
7.46 | Nov 26 |
| Constitutive Activation of STAT3 in Breast Cancer Cells: A Review
Banerjee, K; Resat, H |
Int J Cancer |
2015-11-11 |
7.45 | Nov 19 |
| Dynamic Regulation of Stem Cell Specification and Maintenance by Hypoxia-Inducible Factors
Semenza, GL |
Mol Aspects Med |
2015-11-05 |
7.44 | Nov 12 |
| Peptide Vaccines in Breast Cancer: The Immunological Basis for Clinical Response
de Paula Peres, L; da Luz, FA; Dos Anjos Pultz, B; Brígido, PC; de Araújo, RA; Goulart, LR; Silva, MJ |
Biotechnol Adv |
2015-10-30 |
7.43 | Nov 5 |
| Advances in Small-Molecule Drug Discovery for Triple-Negative Breast Cancer
Fosu-Mensah, N; Peris, MS; Weeks, HP; Cai, J; Westwell, AD |
Future Med Chem |
2015/10/23 |
7.42 | Oct 29 |
| Biological Markers of Invasive Breast Cancer
Matsumoto, A; Jinno, H; Ando, T; Fujii, T; Nakamura, T; Saito, J; Takahashi, M; Hayashida, T; Kitagawa, Y |
Jpn J Clin Oncol |
2015-10-20 |
7.41 | Oct 22 |
| Natural and Therapy-Induced Immunosurveillance in Breast Cancer
Kroemer, G; Senovilla, L; Galluzzi, L; André, F; Zitvogel, L |
Nat Med |
2015-10-07 |
7.40 | Oct 15 |
| Natural and Therapy-Induced Immunosurveillance in Breast Cancer
Kroemer, G; Senovilla, L; Galluzzi, L; André, F; Zitvogel, L |
Nat Med |
2015-10-07 |
7.39 | Oct 8 |
| Macrophage Migration Inhibitory Factor Involvement in Breast Cancer
Saussez, S; Kindt, N; Richard, V |
Int J Oncol |
2015-09-24 |
7.38 | Oct 1 |
| The Role of Steroid Hormones in Breast Cancer Stem Cells
Clarke, RB; Howell, S; Alferez, D: Simoes, BM |
Endocr Relat Cancer |
2015-09-17 |
7.37 | Sep 24 |
| Breast Cancer Cells: Modulation by Melatonin and the Ubiquitin-Proteasome System
Reiter, R; Vriend, J |
Mol Cell Endocrinol |
2015-09-11 |
7.36 | Sep 17 |
| The Roles of ncRNAs and Histone-Modifiers in Regulating Breast Cancer Stem Cells
Lui, S; Song, E; Li, S; Zhao, Z |
Protein Cell |
2015-09-08 |
7.35 | Sep 10 |
| The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review
Du, F; Yuan, P, Wang, T; Zhao, J; Zhao, Z; Luo, Y; Xu, B |
Med Res Rev |
2015-08-27 |
7.34 | Sep 3 |
| The Role of MicroRNAs in the Chemoresistance of Breast Cancer
Han, B; Li, Y; Yang, M; Wang, J |
Drug Dev Res |
2015-08-27 |
7.34 | Sep 3 |
| Of Mice and Women: A Comparative Tissue Biology Perspective of Breast Stem Cells and Differentiation
Ince, TA; Dontu, G |
J Mammary Gland Biol Neoplasia |
2015-08-19 |
7.33 | Aug 27 |
| Analysis of Different HER-2 Mutations in Breast Cancer Progression and Drug Resistance
Sun, Z; Shi, Y; Shen, Y; Cao, L; Zhang, W; Guan, X |
J Cell Mol Med |
2015-08-25 |
7.33 | Aug 27 |
| Impact of Progesterone on Stem/Progenitor Cells in the Human Breast
Clarke, CL; Hilton, HN |
J Mammary Gland Biol Neoplasia |
2015-08-08 |
7.32 | Aug 20 |
| Targeting BCL-2 to Enhance Vulnerability to Therapy in Estrogen Receptor-Positive Breast Cancer
Lindeman, GJ; Visvader, JE; Lok, SW; Merino, D |
Oncogene |
2015-08-10 |
7.31 | Aug 13 |
| Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer
Ren, G; Li, H; Huang, J |
Cytokine Growth Factor Rev |
2015-07-14 |
7.29 | Jul 30 |
| MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
Castiglioni, I; Cava, C; Bertoli, G |
Theronostics |
2015-07-11 |
7.28 | Jul 23 |
| The Role of Inflammation in Progression of Breast Cancer: Friend or Foe?
Jones, LJ; Allen, MD |
Int J Oncol |
2015-07-08 |
7.27 | Jul 16 |
| There and Back Again: The Journey of the Estrogen-Related Receptors in the Cancer Realm
Giguere, V; Tam, I |
J Steroid Biochem Mol Biol |
2015-07-04 |
7.26 | Jul 9 |
| ESR1 Mutations—A Mechanism for Acquired Endocrine Resistance in Breast Cancer
Schiff, R; Brown, M; De Angelis, C; Buchwalter, G; Jeselsohn, R |
Nat Rev Clin Oncol |
2015-06-30 |
7.25 | Jul 2 |
| Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Henry, NL; Morikawa |
Clin Cancer Res |
2015-06-22 |
7.24 | Jun 25 |
| The Molecular, Cellular and Clinical Consequences of Targeting the Estrogen Receptor following Estrogen Deprivation Therapy
Fan, P; Maximov, PY, Curpan, RF; Abderrahman, B; Jordan, VC |
Mol Cell Endocrinol |
2015-06-05 |
7.22 | Jun 11 |
| The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research
Raica, M; Cimpean, AM; Comsa, S |
Anticancer Res |
2015-06-01 |
7.21 | Jun 4 |
| Retinoids Induce Cellular Senescence in Breast Cancer Cells by RAR-β Dependent and Independent Pathways: Potential Clinical Implications
Christov, K; Green, A; Shilkaitis, A |
Int J Oncol |
2015-05-18 |
7.20 | May 28 |
| The Relevance of EMT in Breast Cancer Metastasis: Correlation or Causality?
Christofori, G; Bill, R |
FEBS Lett |
2015-05-12 |
7.19 | May 21 |
| Circulating Tumor Cell Clusters-Associated Gene Plakoglobin and Breast Cancer Survival
Ma, W; Gu, X; Zeng, H; Lu, L |
Breast Cancer Res Treat |
2015-05-10 |
7.18 | May 14 |
| Is Androgen Receptor Targeting an Emerging Treatment Strategy for Triple Negative Breast Cancer?
Papavassiliou, A; Dalagiorgou, G; Karamouzis, M; Anestis, A |
Cancer Treat Rev |
2015-04-28 |
7.17 | May 7 |
| Molecular Characterization and Targeted Therapeutic Approaches in Breast Cancer
Cristofanilli, M; Toss, A |
Breast Cancer Res |
2015-04-23 |
7.16 | Apr 30 |
| Identifying and Targeting Tumor-Initiating Cells in the Treatment of Breast Cancer
Lewis, M; Wei, W |
Endocr-Relat Cancer |
2015-04-15 |
7.15 | Apr 23 |
| Molecular Characterization and Targeted Therapeutic Approaches in Breast Cancer
Cristofanilli, M; Toss, A |
Breast Cancer Res |
2015-04-23 |
7.15 | Apr 23 |
| Insights into the Key Roles of Proteoglycans in Breast Cancer Biology and Translational Medicine
Therocharis, A; Karamanos, N |
Biochim Biophys Acta |
2015-03-28 |
7.13 | Apr 9 |
| Mcf-7 Cells-Changing the Course of Breast Cancer Research and Care for 45 Years
Davidson, NE; Oesterreich, S; Lee, AV |
J Natl Cancer Inst |
2015-03-31 |
7.12 | Apr 2 |
| Recurrence and Metastasis of Breast Cancer Is Influenced by Ovarian Hormone’s Effect on Breast Cancer Stem Cells
Lakshmanaswamy, R; de la Rosa, JM; Arumugam, A; Subramani, R; Nahleh, Z; Gangwani, L; Nandy, SB |
Future Oncol |
2015-04-11 |
7.10 | Mar 19 |
| The Novel Role of miRNAs for Tamoxifen Resistance in Human Breast Cancer
Guan, X; Zhang, Q; Sun, Q; Shi, Y; Xu, J; Zhang, W |
Cell Mol Life Sci |
2015-03-18 |
7.10 | Mar 19 |
| Role of Inflammatory Infiltrates in Triple Negative Breast Cancer
Igbal, J; Tan, PH; Dent, R; Koo, SL; Matsumoto, H |
J Clin Pathol |
2015-03-06 |
7.09 | Mar 12 |
| Role of miR-155 in Drug Resistance of Breast Cancer
Zhoa, JH; Tang, JH; Ma, TF; Chen, L; Zhang, XH; Zhong, SL; Chen, WX, Lv, MM; Yu, DD |
Tumor Biology |
2015-03-06 |
7.09 | Mar 12 |
| Metastatic Breast Cancer: The Potential of miRNA for Diagnosis and Treatment Monitoring
McGuire, A; Brown, JA; Kerin, MJ |
Cancer Metastasis Rev |
2015-02-27 |
7.08 | Mar 5 |
| The Origin of Breast Tumor Heterogeneity
Skibinski, A; Kuperwasser, C |
Oncogene |
2015-02-23 |
7.07 | Feb 26 |
| Management of Locally Advanced Breast Cancer—Perspectives and Future Directions
Tryfonidis, K; Senkus, E; Cardoso, MJ; Cardoso, F |
Nat Rev Clin Oncol |
2015-02-10 |
7.06 | Feb 19 |
| miRNAs Regulated by Estrogens, Tamoxifen, and Endocrine Disruptors and Their Downstream Gene Targets
Klinge, CM |
Mol Cell Endocrinol |
2015-02-03 |
7.05 | Feb 12 |
| MicroRNAs in Breast Cancer: Regulatory Roles Governing the Hallmarks of Cancer
Kumar, A; Yap, C; Lobie, P; Lee, A; Dharmarajan, A; Chan, M; Kim, J; Wang, C; Shin, E; Cai, W; Yap, W; Siveen, K; Datta, A; Loo, S; Goh, J |
Biol Rev |
2015-01-28 |
7.04 | Feb 5 |
| Regulation of Cell Signaling and Apoptosis by Tumor Suppressor WWOX
Hsu, LJ; Lai, FJ; C, YT; Lo, JY |
Exp Biol Med |
2015-01-16 |
7.03 | Jan 29 |
| Estrogen Receptor Alpha Phosphorylation and Its Functional Impact in Human Breast Cancer
Rowan, B; Anbalagan, M |
Mol Cell Endocrinol |
2015-01-15 |
7.02 | Jan 22 |
| Molecular Mechanism and Clinical Impact of APOBEC3B-Catalyzed Mutagenesis in Breast Cancer
Harris, RS |
Breast Cancer Res |
2015-01-21 |
7.02 | Jan 22 |
| Targeting HER2 for the Treatment of Breast Cancer
Osborne, CK; Schiff, R; Rimawi, MF |
Annu Rev Med |
2015-01-14 |
7.01 | Jan 15 |
| Mammary Lineage Tracing: The Coming of Age
Sale, S; Pavelic, K |
Cell Mol Life Sci |
2015-01-07 |
7.00 | Jan 8 |
| Inhibitor of Differentiation 4 (ID4): From Development to Cancer
Patel, D; Morton, DJ; Carey, J; Havrda, MC; Chaudhary, J |
Biochim Biophys Acta |
2014-12-12 |
6.49 | Dec 18 |
| Roles of the WWOX in Pathogenesis and Endocrine Therapy of Breast Cancer
Li, J; Liu, J; Ren, Y; Liu, P |
Exp Biol Med |
2014-12-04 |
6.48 | Dec 11 |
| Hippo Pathway in Mammary Gland Development and Breast Cancer
Shi, P; Feng, J; Chen, C |
Acta Biochim Biophys Sin |
2014-12-02 |
6.47 | Dec 4 |
| Animal Models for Exploring the Pharmacokinetics of Breast Cancer Therapies
Rashid, OM; Takabe, K |
Expert Opin Drug Metab Toxicol |
2014-11-21 |
6.46 | Nov 27 |
| Local Therapy for Breast Cancer in the Molecular Era: Relevant or Relic?
Farr, D; Khan, SA |
Oncology |
2014-11-15 |
6.45 | Nov 20 |
| Wip1 Phosphatase in Breast Cancer
Emelyanov, A; Bulavin, DV |
Oncogene |
2014-11-10 |
6.44 | Nov 13 |
| Applying Synthetic Lethality for the Selective Targeting of Cancer
McLornan, DP; List, A; Mufti, GJ |
New Engl J Med |
2014-10-30 |
6.43 | Nov 6 |
| DNA Methylome Profiling beyond Promoters: Taking an Epigenetic Snapshot of the Breast Tumor Microenvironment
Jeschke, J; Collignon, E; Fuks, F |
FEBS J |
2014-10-21 |
6.42 | Oct 30 |
| Topoisomerase IIα in Chromosome Instability and Personalized Cancer Therapy
Chen, T; Sun, Y; Ji, P; Kopetz, S; Zhang, W |
Oncogene |
2014-10-20 |
6.41 | Oct 23 |
| Triple-Negative Breast Cancer: Investigating Potential Molecular Therapeutic Target
Papa, A; Caruso, D; Tomao, S; Rossi, L; Zaccarelli, E; Tomao, F |
Exp Opin Ther Targets |
2014-10-13 |
6.41 | Oct 23 |
| An Update on PARP Inhibitors – Moving to the Adjuvant Setting
Sonnenblick, A; de Azambuja, E; Azim, HA; Piccart, M |
Nat Rev Clin Oncol |
2014-10-07 |
6.40 | Oct 16 |
| Obesity, Proinflammatory Mediators, Adipose Tissue Progenitors, and Breast Cancer
Bertolini, F; Orecchioni, S; Petit, JY; Kolonin, MG |
Curr Opin Oncol |
2014-10-01 |
6.39 | Oct 9 |
| The Network of Epithelial–Mesenchymal Transition: Potential New Targets for Tumor Resistance
Nantajit, D; Lin, D; Li, JJ |
J Cancer Res Clin Oncol |
2014-10-01 |
6.38 | Oct 2 |
| DEAR1, a Novel Tumor Suppressor that Regulates Cell Polarity and Epithelial Plasticity
Chen, N; Balasenthil, S; Reuther, J; Killary, AM |
Cancer Res |
2014-09-26 |
6.38 | Oct 2 |
| Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport-An Update
Unadkat, J; Mao, Q |
AAPS J |
2014-09-14 |
6.37 | Sep 25 |
| Functional Role of the MicroRNA-200 Family in Breast Morphogenesis and Neoplasia
Hilmarsdottir, B; Briem, E; Bergthorsson, JT; Magnusson, MK; Gudjonsson, T |
Genes |
2014-09-11 |
6.36 | Sep 18 |
| TMPRSS4: An Emerging Potential Therapeutic Target in Cancer
de Aberasturi, AL; Calvo, A |
Br J Cancer |
2014-09-09 |
6.35 | Sep 11 |
| Estrogen Metabolites and Breast Cancer
Santen, RJ; Yue, W; Wang, JP |
Steroids |
2014-08-26 |
6.34 | Sep 4 |
| Implications of Stemness-Related Signaling Pathways in Breast Cancer Response to Therapy
Angeloni, V; Tiberio, P; Appierto, V; Daidone, MG |
Semin Cancer Biol |
2014-08-18 |
6.33 | Aug 28 |
| The Significance of Circulating Tumour Cells in Breast Cancer: A Review
Castle, J; Shaker, H; Morris, K; Tugwood, JD; Kirwan, CC |
Breast |
2014-08-11 |
6.32 | Aug 21 |
| MicroRNAs as Regulatory Elements in Triple Negative Breast Cancer
Gyparaki, MT; Basdra, EK; Papavassiliou, AG |
Cancer Lett |
2014-08-10 |
6.32 | Aug 21 |
| FAK in Cancer: Mechanistic Findings and Clinical Applications
Sulzmaier, FJ; Jean, C; Schlaepfer, DD |
Nat Rev Cancer |
2014-08-07 |
6.31 | Aug 14 |
| The Mammary Cellular Hierarchy and Breast Cancer
Oakes, SR; Gallego-Ortega, D; Ormandy, CJ |
Cell Mol Life Sci |
2014-07-31 |
6.30 | Aug 7 |
| The Receptor Tyrosine Kinase ROR1 – An Oncofetal Antigen for Targeted Cancer Therapy
Hojjat-Farsangi, M; Moshfegh, A; Daneshmanesh, AH; Khan, AS; Mikaelsson, E; Österborg, A; Mellstedt, H |
Semin Cancer Biol |
2014-07-25 |
6.29 | Jul 31 |
| Interplay between Estrogen and Retinoid Signaling in Breast Cancer – Current and Future Perspectives
Ribeiro, MPC; Santos, AE; Custódio, JBA |
Cancer Lett |
2014-07-17 |
6.28 | Jul 24 |
| HER2-Positive Advanced Breast Cancer: Optimizing Patient Outcomes and Opportunities for Drug Development
Singh, JC; Jhaveri, K; Esteva, FJ |
J Mammary Gland Biol Neoplasia |
2014-07-15 |
6.27 | Jul 17 |
| Breast Cancer Stem Cells and the Immune System: Promotion, Evasion and Therapy
Boyle, ST; Kochetkova, M |
J Mammary Gland Biol Neoplasia |
2014-07-06 |
6.26 | Jul 10 |
| Non-Conventional Functions for NF-κB Members: The Dark Side of NF-κB
Espinosa; L, Margalef, P; Bigas, A |
Oncogene |
2014-06-30 |
6.25 | Jul 3 |
| Mammary Gland Involution as an Immunotherapeutic Target for Postpartum Breast Cancer
Fornetti, J; Martinson, HA; Betts, CB; Lyons, TR; Jindal, S; Guo, Q; Coussens, LM; Borges, VF; Schedin, P |
J Mammary Gland Biol Neoplasia |
2014-06-22 |
6.24 | Jun 24 |
| X-Chromosome Inactivation in Development and Cancer
Chaligné, R; Heard, E |
FEBS Lett |
2014-06-14 |
6.23 | Jun 19 |
| The Impact of Tumor Stroma on Drug Response in Breast Cancer
Dittmer, J; Leyh, B |
Semin Cancer Biol |
2014-06-06 |
6.22 | Jun 12 |
| Non-Viral Nanocarriers for siRNA Delivery in Breast Cancer
Zhang, J; Li, X; Huang, L |
J Control Release |
2014-05-26 |
6.21 | Jun 5 |
| Mechanisms Associated with Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer
Viedma-Rodríguez, R; Baiza-Gutman, L; Salamanca-Gómez, F; Diaz-Zaragoza, M; Martínez-Hernández, G; Ruiz Esparza-Garrido, R; Velázquez-Flores, MA; Arenas-Aranda, D |
Oncol Rep |
2014-05-16 |
6.20 | May 29 |
| Hierarchy of Breast Cancer Cells: Key to Reverse Dormancy for Therapeutic Intervention
Bliss, SA; Greco, SJ; Rameshwar, P |
Stem Cells Transl Med |
2014-05-15 |
6.19 | May 22 |
| A Fine-Scale Dissection of the DNA Double-Strand Break Repair Machinery and Its Implications for Breast Cancer Therapy
Liu, C; Srihari, S; Cao, KA; Chenevix-Trench, G; Simpson, PT; Ragan, MA; Khanna, KK |
Nucleic Acids Res |
2014-05-12 |
6.18 | May 15 |
| Engineering Mammary Gland In Vitro Models for Cancer Diagnostics and Therapy
Campbell, JJ; Hume, RD; Watson, CJ |
Mol Pharm |
2014-04-25 |
6.17 | May 8 |
| Mimicking Breast Cancer-Induced Bone Metastasis In Vivo: Current Transplantation Models and Advanced Humanized Strategies
Thibaudeau, L; Quent, VM; Holzapfel, BM; Taubenberger, AV; Straub, M; Hutmacher, DW |
Cancer Metastasis Rev |
2014-04-27 |
6.16 | May 1 |
| The Intracrinology of Breast Cancer
McNamara, KM; Sasano, H |
J Steroid Biochem Mol Biol |
2014-04-18 |
6.15 | Apr 24 |
| Breast Cancer Stem Cells: Multiple Capacities in Tumor Metastasis
Geng, SQ; Alexandrou, AT; Li, JJ |
Cancer Lett |
2014-04-12 |
6.14 | Apr 17 |
| Mechanisms of RET Signaling in Cancer: Current and Future Implications for Targeted Therapy
Plaza-Menacho, I; Mologni, L; McDonald, NQ |
Cell Signal |
2014-04-03 |
6.13 | Apr 10 |
| Regulation of Mammary Epithelial Cell Homeostasis by lncRNAs
Shore, AN; Rosen, JM |
Int J Biochem Cell Biol |
2014-03-26 |
6.12 | Apr 3 |
| MicroRNAs: A New Class of Breast Cancer Biomarkers
Mulrane, L; Klinger, R; McGee, SF; Gallagher, WM; O’Connor, DP |
Expert Rev Mol Diagn |
2014-04-01 |
6.11 | Mar 27 |
| Rewiring Cell Polarity Signaling in Cancer
Halaoui, R; McCaffrey, L |
Oncogene |
2014-03-17 |
6.10 | Mar 20 |
| The Emergence of Targeted Drugs in Breast Cancer to Prevent Resistance to Endocrine Treatment and Chemotherapy
Austreid, E; Lonning, PE; Eikesdal, HP |
Expert Opin Pharmacother |
2014-02-28 |
6.09 | Mar 13 |
| The Therapeutic Role of Fulvestrant in the Management of Patients with Hormone Receptor-Positive Breast Cancer
Ciruelos, E; Pascual, T; Vozmediano, MLA; Blanco, M; Manso, L; Parilla, L; Munoz, C; Vega, E; Calderon, MJ; Sancho, B; Cortes-Funes, H |
Breast |
2014-03-04 |
6.08 | Mar 6 |
| BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different
Burgess, M; Puhalla, S |
Front Oncol |
2014-02-25 |
6.08 | Mar 6 |
| Nutrient Transport in the Mammary Gland: Calcium, Trace Minerals and Water Soluble Vitamins
Montalbetti, N; Dalghi, MG; Albrecht, C; Hediger, MA |
J Mammary Gland Biol Neoplasia |
2014-02-25 |
6.07 | Feb 27 |
| HER2 in Breast Cancer: A Review and Update
Krishnamurti, U; Silverman, JF |
Adv Anat Pathol |
2014-03-01 |
6.06 | Feb 20 |
| Aberrant DNA Methylation of MicroRNA Genes in Human Breast Cancer – A Critical Appraisal
Lehmann, U |
Cell Tissue Res |
2014-02-09 |
6.05 | Feb 13 |
| Iron Homeostasis in Breast Cancer
Marques, O; da Silva, BM; Porto, G; Lopes, C |
Cancer Lett |
2014-01-31 |
6.04 | Feb 6 |
| Estrogen Receptor (ER) α Mutations in Breast Cancer: Hidden in Plain Sight
Fuqua, SAW; Gu, G; Rechoum, Y |
Breast Cancer Res Treat |
2014-02-01 |
6.04 | Feb 6 |
| Reproductive Risk Factors and Breast Cancer Subtypes: A Review of the Literature
Anderson, KN; Schwab, RB; Martinez, ME |
Breast Cancer Res Treat |
2014-01-30 |
6.03 | Jan 30 |
| Triple-Negative Breast Cancer: Molecular Subtypes and Targeted Therapy
Hirshfield, KM; Ganesan, S |
Curr Opin Obstet Gynecol |
2014-02-01 |
6.02 | Jan 23 |
| Stress Signaling and the Shaping of the Mammary Tissue in Development and Cancer
Avivar-Valderas, A; Wen, HC; Aguirre-Ghiso, JA |
Oncogene |
2014-01-13 |
6.01 | Jan 16 |
| The Optimal Duration of Adjuvant Endocrine Therapy for Early Stage Breast Cancer – With What Drugs and for How Long?
Johnston, SRD; Yeo, B |
Curr Oncol Rep |
2014-01-04 |
6.00 | Jan 9 |
| How Pregnancy at Early Age Protects against Breast Cancer
Meier-Abt, F; Bentires-Alj, M |
Trends Mol Med |
2013-12-17 |
5.50 | Dec 19 |
| Adoptive Immunotherapy of Metastatic Breast Cancer: Present and Future
Stefanovic, S; Schuetz, F; Sohn, C; Beckhove, P; Domschke, C |
Cancer Metastasis Rev |
2013-12-13 |
5.50 | Dec 19 |
| The Biology of Zinc Transport in Mammary Epithelial Cells: Implications for Mammary Gland Development, Lactation, and Involution
McCormick, NH; Hennigar, SR; Kiselyov, K; Kelleher, SL |
J Mammary Gland Biol Neoplasia |
2013-12-15 |
5.50 | Dec 19 |
| Role of Sphingolipids in Estrogen Signaling in Breast Cancer Cells: An Update
Sukocheva, OA; Wadham, C |
J Endocrinol |
2013-12-09 |
5.49 | Dec 12 |
| Tackling the Diversity of Triple-Negative Breast Cancer
Turner, NC; Reis-Filho; JS |
Clin Cancer Res |
2013-12-01 |
5.48 | Dec 5 |
| MicroRNAs Delivered by Extracellular Vesicles: An Emerging Resistance Mechanism for Breast Cancer
Zhao, JH; Tang, JH |
Tumor Biol |
2013-11-12 |
5.47 | Nov 28 |
| The Role of Tight Junctions in Mammary Gland Function
Stelwagen, K; Singh, K |
J Mammary Gland Biol Neoplasia |
2013-11-19 |
5.46 | Nov 21 |
| miRNA Dysregulation in Breast Cancer
Mulrane, L; McGee, SF; Gallagher, WM; O’Connor, DP |
Cancer Res |
2013-11-07 |
5.45 | Nov 14 |
| Breakthroughs in Research and Treatment of Early Breast Cancer: An Overview of the Last Three Decades
Loibl, S |
Arch Gynecol Obstet |
2013-11-05 |
5.44 | Nov 7 |
| Role of Adipokines and Cytokines in Obesity-Associated Breast Cancer: Therapeutic Targets
Khan, S; Shukla, S; Sinha, S; Meeran, SM |
Cytokine Growth Factor Rev |
2013-10-21 |
5.43 | Oct 31 |
| Clinical Application of High-Throughput Genomic Technologies for Treatment Selection in Breast Cancer
Hansen, AR; Bedard, PL |
Breast Cancer Res |
2013-10-18 |
5.42 | Oct 24 |
| New Approaches for Hormone-Receptor Positive Metastatic Breast Cancer
Thanopoulou, E; Johnston, SRD |
Curr Opin Oncol |
2013-10-10 |
5.41 | Oct 17 |
| Suitable Trial Designs and Cohorts for Preventive Breast Cancer Agents
Strasser-Weippl, K; Goss, PE |
Nat Rev Clin Oncol |
2013-10-08 |
5.40 | Oct 10 |
| Immunotherapeutics for Breast Cancer
Criscitiello, C; Curigliano, G |
Curr Opin Oncol |
2013-11-01 |
5.39 | Oct 3 |
| Circulating Nucleic Acids as Biomarkers in Breast Cancer
Schwarzenbach, H |
Breast Cancer Res |
2013-09-26 |
5.38 | Sep 26 |
| Targeting IL-8 Signalling to Inhibit Breast Cancer Stem Cell Activity
Singh, JK; Simões, BM; Clarke, RB; Bundred, NJ |
Expert Opin Ther Targets |
2013-09-14 |
5.37 | Sep 17 |
| Biology and Therapeutic Potential of PI3K Signaling in ER+/HER2-Negative Breast Cancer
Fu, X; Osborne, CK; Schiff, R |
Breast |
2013-09-05 |
5.36 | Sep 12 |
| Genomic and Non-Genomic Actions of Progestogens in the Breast
Mueck, AO; Ruan, X; Seeger, H; Fehm, T; Neubauer, H |
J Steroid Biochem Mol Biol |
2013-08-27 |
5.35 | Sep 5 |
| Breast Cancer Adaptive Resistance: HER2 and Cancer Stem Cell Repopulation in a Heterogeneous Tumor Society
Duru, N; Candas, D; Jiang, G; Li, JJ |
J Cancer Res Clin Oncol |
2013-08-30 |
5.35 | Sep 5 |
| Pertuzumab: A Review of Its Use for First-Line Combination Treatment of HER2-Positive Metastatic Breast Cancer
McCormack, PL |
Drugs |
2013-09-01 |
5.34 | Aug 29 |
| Opportunities and Hurdles in the Treatment of BRCA1-Related Breast Cancer
Drost, R; Jonkers, J |
Oncogene |
2013-08-19 |
5.33 | Aug 22 |
| Pertuzumab: Optimizing HER2 Blockade
Metzger-Filho, O; Winer, EP; Krop, I |
Breast Cancer Res |
2013-08-13 |
5.32 | Aug 15 |
| Platelets; Coagulation and Fibrinolysis in Breast Cancer Progression
Lal, I; Dittus, K; Holmes, CE |
Breast Cancer Res |
2013-07-31 |
5.31 | Aug 8 |
| How Integrins Control Breast Biology
Glukhova, MA; Streuli, CH |
Curr Opin Cell Biol |
2013-07-22 |
5.30 | Aug 1 |
| Differential Chemotherapeutic Sensitivity for Breast Tumors with “BRCAness”: A Review
Chalasani, P; Livingston, R |
Oncologist |
2013-07-23 |
5.29 | Jul 25 |
| Use of Pertuzumab for the Treatment of HER2-Positive Metastatic Breast Cancer
De Mattos-Arruda, L; Cortes, J |
Adv Ther |
2013-07-24 |
5.29 | Jul 25 |
| Myeloid-Derived Suppressor Cells in Breast Cancer
Markowitz, J; Wesolowski, R; Papenfuss, T; Brooks, TR; Carson, WE 3rd |
Breast Cancer Res Treat |
2013-07-05 |
5.28 | Jul 18 |
| Benzyl Isothiocyanate: Double Trouble for Breast Cancer Cells
Rao, CV |
Cancer Prev Res |
2013-07-10 |
5.27 | Jul 11 |
| Pertuzumab in Breast Cancer: A Systematic Review
Zagouri, F; Sergentanis, TN; Chrysikos, D; Zografos, CG; Filipits, M; Bartsch, R; Dimopoulos, MA |
Clin Breast Cancer |
2013-06-27 |
5.26 | Jul 4 |
| The Immune System and Inflammation in Breast Cancer
Jiang, X; Shapiro, DJ |
Mol Cell Endocrinol |
2013-06-19 |
5.25 | Jun 27 |
| Clinical Challenges in the Molecular Characterization of Circulating Tumour Cells in Breast Cancer
Lianidou, ES; Mavroudis, D; Georgoulias, V |
Br J Cancer |
2013-06-11 |
5.23 | Jun 13 |
| Targeted Therapy for HER2 Positive Breast Cancer
Mohamed, A; Krajewski, K; Cakar, B; Ma, CX |
J Hematol Oncol |
2013-08-28 |
5.22 | Jun 6 |
| Progesterone Signaling in Breast Cancer: A Neglected Hormone Coming Into the Limelight
Brisken, C |
Nat Rev Cancer |
2013-06-01 |
5.21 | May 30 |
| Delivery of Gene Silencing Agents for Breast Cancer Therapy
Shen, H; Mittal, V; Ferrari, M; Chang, J |
Breast Cancer Res |
2013-05-08 |
5.18 | May 9 |
| Breast cancer: Improving Mouse Models
Seton-Rogers, S |
Nat Rev Cancer |
2013-05-01 |
5.17 | May 2 |
| Pharmacogenomics of Endocrine Therapy in Breast Cancer
Ingle, JN |
J Hum Genet |
2013-05-02 |
5.17 | May 2 |
| The Estrogen-Regulated Anterior Gradient 2 (AGR2) Protein in Breast Cancer: A Potential Drug Target and Biomarker
Salmans, ML; Zhao, F; Andersen, B |
Breast Cancer Res |
2013-04-24 |
5.16 | Apr 25 |
| Active Immunotherapy in HER2 Overexpressing Breast Cancer: Current Status and Future Perspectives
Milani, A; Sangiolo, D; Montemurro, F; Aglietta, M; Valabrega, G |
Ann Oncol |
2013-04-12 |
5.15 | Apr 18 |
| Intrathecal Administration of Trastuzumab for the Treatment of Meningeal Carcinomatosis in HER2-Positive Metastatic Breast Cancer: A Systematic Review and Pooled Analysis
Zagouri, F; Sergentanis, TN; Bartsch, R; Berghoff, AS; Chrysikos, D; de Azambuja, E; Dimopoulos, MA; Preusser, M |
Breast Cancer Res Treat |
2013-04-16 |
5.15 | Apr 18 |
| Postmenopausal Breast Cancer; Androgens; and Aromatase Inhibitors
Campagnoli, C; Pasanisi, P; Castellano, I; Abbà, C; Brucato, T; Berrino, F |
Breast Cancer Res Treat |
2013-04-10 |
5.14 | Apr 11 |
| Metabolic Syndrome and Postmenopausal Breast Cancer: Systematic Review and Meta-Analysis
Esposito, K; Chiodini, P; Capuano, A; Bellastella, G; Maiorino, MI; Rafaniello, C; Giugliano, D |
Menopause |
2013-04-08 |
5.14 | Apr 11 |
| The Hedgehog Signaling Pathway in Breast Development; Carcinogenesis and Cancer Therapy
Hui, M; Cazet, A; Nair, R; Watkins, DN; O’Toole, SA; Swarbrick, A |
Breast Cancer Res |
2013-03-28 |
5.13 | Apr 4 |
| Signaling Cross-Talk in the Resistance to HER Family Receptor Targeted Therapy
Yamaguchi, H; Chang, SS; Hsu, JL; Hung, MC |
Oncogene |
2013-04-01 |
5.13 | Apr 4 |
| A Bi-Faceted Role of Estrogen Receptor Beta in Breast Cancer
Leygue, E; Murphy, LC |
Endocr Relat Cancer |
2013-03-25 |
5.12 | Mar 28 |
| The Role of Intratumoral and Systemic IL-6 in Breast Cancer
Dethlefsen, C; Højfeldt, G; Hojman, P |
Breast Cancer Res Treat |
2013-03-27 |
5.12 | Mar 28 |
| Pharmacogenomics of Breast Cancer Therapy: An Update
Westbrook, K; Stearns, V |
Pharmacol Ther |
2013-03-13 |
5.11 | Mar 21 |
| Polarity Proteins as Regulators of Cell Junction Complexes: Implications for Breast Cancer
Bazzoun, D; Lelièvre, S; Talhouk, R |
Pharmacol Ther |
2013-02-28 |
5.10 | Mar 14 |
| Emerging Targeted Agents in Metastatic Breast Cancer
Zardavas, D; Baselga, J; Piccart, M |
Nat Rev Clin Oncol |
2013-03-05 |
5.09 | Mar 7 |
| Male Breast Cancer: Risk Factors; Biology; Diagnosis; Treatment; and Survivorship
Ruddy, KJ; Winer, EP |
Ann Oncol |
2013-02-20 |
5.08 | Feb 28 |
| Exposures to Synthetic Estrogens at Different Times During the Life; and Their Effect on Breast Cancer Risk
Hilakivi-Clarke, L; de Assis, S; Warri, A |
J Mammary Gland Biol Neoplasia |
2013-02-08 |
5.07 | Feb 21 |
| Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis
Amith, SR; Fliegel, L |
Cancer Res |
2013-02-07 |
5.06 | Feb 14 |
| CCL5 as a Potential Immunotherapeutic Target in Triple-Negative Breast Cancer
Lv, D; Zhang, Y; Kim, HJ; Zhang, L; Ma, X |
Cell Mol Immunol |
2013-02-04 |
5.05 | Feb 7 |
| Mammary Stem Cell Research in Veterinary Science: An Update
Borena, BM; Bussche, L; Burvenich, C; Duchateau, L; Van de Walle, GR |
Stem Cells Dev |
2013-01-29 |
5.04 | Jan 31 |
| Estrogen-Related Receptors in Breast Cancer: Control of Cellular Metabolism and Beyond
Deblois, G; Giguère, V |
Nat Rev Cancer |
2013-01-01 |
5.04 | Jan 31 |
| Progesterone Action in Endometrial Cancer; Endometriosis; Uterine Fibroids; and Breast Cancer
Kim, JJ; Kurita, T; Bulun, SE |
Endocr Rev |
2013-01-09 |
5.02 | Jan 17 |
| Role of MicroRNAs in Breast Cancer
Singh, R; Mo, YY |
Cancer Biol Ther |
2013-01-04 |
5.01 | Jan 10 |
| Impaired Mitochondrial Metabolism and Mammary Carcinogenesis
Yadava, N; Schneider, SS; Jerry, DJ; Kim, C |
J Mammary Gland Biol Neoplasia |
2012-12-27 |
5.00 | Jan 3 |
| Emerging Strategies for the Dual Inhibition of HER2-Positive Breast Cancer
Konecny, GE |
Curr Opin Obstet Cynecol |
2013-02-01 |
4.50 | Dec 20 |
| Transglutaminase 2 and NF-κB: An Odd Couple that Shapes Breast Cancer Phenotype
Brown, KD |
Breast Cancer Res Treat |
2012-12-08 |
4.49 | Dec 13 |
| Ductal Carcinoma In Situ; Sentinel Lymph Nodes and Low Volume Metastatic Disease and Reporting of Neoadjuvant Chemotherapy Specimens
Provenzano, E; Brown, JP; Pinder, SE |
Clin Oncol |
2012-11-27 |
4.48 | Dec 6 |
| RUNX2 in Mammary Gland Development and Breast Cancer
Ferrari, N; McDonald, L; Morris, JS; Cameron, ER; Blyth, K |
J Cell Physiol |
2012-11-20 |
4.47 | Nov 29 |
| Stat5 in Breast Cancer: Potential Oncogenic Activity Coincides with Positive Prognosis for the Disease
Barash, I |
Carcinogenesis |
2012-11-16 |
4.46 | Nov 22 |
| Management of the Axilla in Early Breast Cancer Patients in the Genomic Era
Oliveira, M; Cortés, J; Bellet, M; Balmaña, J; De Mattos-Arruda, L; Gómez, P; Muñoz, E; Ortega, V; Pérez, J; Saura, C; Vidal, M; Rubio, IT; Di Cosimo, S |
Ann Oncol |
2012-11-19 |
4.46 | Nov 22 |
| Emerging Treatment Options for the Management of Brain Metastases in Patients with HER2-Positive Metastatic Breast Cancer
Chien, AJ; Rugo, HS |
Breast Cancer Res Treat |
2012-11-10 |
4.45 | Nov 15 |
| Cytokines; Obesity; and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression
Gilbert, CA; Slingerland, JM |
Annu Rev Med |
2012-10-26 |
4.44 | Nov 8 |
| Breast Cancer Stem Cells: A Novel Therapeutic Target
Gangopadhyay, S; Nandy, A; Hor, P; Mukhopadhyay, A |
Clin Breast Cancer |
2012-11-03 |
4.44 | Nov 8 |
| Hide and Seek: Tell-Tale Signs of Breast Cancer Lurking in the Blood
Guttery, DS; Blighe, K; Page, K; Marchese, SD; Hills, A; Coombes, RC; Stebbing, J; Shaw, JA |
Cancer Metastasis Rev |
2013-06-01 |
4.43 | Nov 1 |
| Characterization of Tumor Differentiation Factor (TDF) and Its Receptor (TDF-R)
Sokolowska, I; Woods, AG; Gawinowicz, MA; Roy, U; Darie, CC |
Cell Mol Life Sci |
2012-10-18 |
4.42 | Oct 25 |
| New Strategies for Targeting the Hypoxic Tumor Microenvironment in Breast Cancer
Ward, C; Langdon, SP; Mullen, P; Harris, AL; Harrison, DJ; Supuran, CT; Kunkler, IH |
Cancer Treat Rev |
2012-10-12 |
4.41 | Oct 18 |
| The RUNX Family in Breast Cancer: Relationships with Estrogen Signaling
Chimge, NO; Frenkel, B |
Oncogene |
2012-10-08 |
4.40 | Oct 11 |
| The Need for Lymph Node Dissection in Nonmetastatic Breast Cancer
Pesce, C; Morrow, M |
Ann Rev Med |
2012-09-27 |
4.39 | Oct 4 |
| When to Order a Biopsy to Characterise a Metastatic Relapse in Breast Cancer
Foukakis, T; Åström, G; Lindström, L; Hatschek, T; Bergh, J |
Ann Oncol |
2012-10-01 |
4.38 | Sep 27 |
| mTOR Inhibitors in Breast Cancer: A Systematic Review
Vinayak, S; Carlson, RW |
Gyncel Oncol |
2012-09-06 |
4.37 | Sep 20 |
| Body Composition Changes in Females Treated for Breast Cancer: A Review of the Evidence
Sheean, PM; Hoskins, K; Stolley, M |
Breast Cancer Res Treat |
2012-08-19 |
4.36 | Sep 13 |
| Effect of Obesity on Toxicity in Women Treated with Adjuvant Chemotherapy for Early-Stage Breast Cancer: A Systematic Review
Carroll, J; Protani, M; Walpole, E; Martin, JH |
Breast Cancer Res Treat |
2012-08-24 |
4.34 | Aug 30 |
| Lapatinib; Trastuzumab or the Combination Added to Preoperative Chemotherapy for Breast Cancer: A Meta-Analysis of Randomized Evidence
Valachis, A; Nearchou, A; Lind, P; Mauri, D |
Breast Cancer Res Treat |
2012-08-09 |
4.33 | Aug 23 |
